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ABSTRACT 
 
 
HUI LIU: A STUDY OF PROSTATE CANCER BY USING SINGLE-VOXEL AND 
MULTI-VOXEL TWO-DIMENSIONAL LOCALIZED COSY AND JPRESS MR 
SPECTROSCOPY TECHNIQUES 
 
(Under the direction of Orhan Nalcioglu) 
 
Prostate cancer is the most common cancer among men in the western countries. It grows 
indolently and can take more than 10 years to turn deadly. Currently no imaging methods can 
provide both high sensitivity and specificity for prostate cancer detection and 
characterization.  
1
H Magnetic Resonance Spectroscopy (MRS) is a non-invasive technique, which can 
provide biochemical information of the prostate gland. (Choline + Creatine)/ Citrate ratio is 
widely used as a criterion for the diagnosis of prostate cancer. The specificity of multi-voxel 
1D* 
1
H MRS is still limited due to the severe overlap of 1D* 
1
H MRS spectrum and voxel 
bleeding artifacts. Two-dimensional 
1
H MRS, which spreads the metabolite resonance peaks 
on a two-spectral dimensional surface, can help to differentiate most of the overlapping 
resonance peaks compared to conventional 1D* MRS spectrum.  
In the present study, a Hadamard multi-voxel 2D* localized COrrelated SpectroscopY 
(COSY) MRS technique was developed and implemented on a whole-body 4T MR system.  
The combination of localized 2D* 
1
H MR correlation spectroscopy and Hadamard encoding 
enables the simultaneous acquisition of multiple volumes of interest with the benefits of 
improved spectral resolution, increased SNR without an increase in the experimental duration, 
 iv 
and with limited voxel bleeding compared to 1D* CSI acquisition.  Most of the metabolites 
were measured without contamination of other resonances. The developed technique solves 
the severe resonances overlap problem in 1D* 
1
H MR spectra and offers multi-regional 
analysis of MRS due to the multi-focal and heterogeneous nature of prostate adeno-
carcinoma, which can be easily overlooked by a single-voxel based MR spectroscopy method.   
By using this technique, more metabolites can be identified and additional information 
about the metabolites can be gained from the extended 2D* MRS spectra. This offers an 
opportunity to accurately follow up the metabolism in vivo.  New biomarker of prostate 
cancer –polyamine spermine resonances are very well-resolved in 2D* L-COSY spectra and 
can be traced longitudinally by its cross-peaks for chemoprevention research of prostate 
cancer.  
2D* Localized J-resolved Pointed RESolved Spectroscopy (JPRESS) MRS technique 
was also implemented to compare it with the 2D* L-COSY technique. The advantages and 
disadvantages of both techniques are thoroughly investigated.  
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Chapter 1 
 
Introduction 
     
1.1 Background 
 
Prostate cancer is the most common cancer among men and the second leading cause of 
cancer mortality (after lung cancer) in the United States. It accounts for about 30% of all 
cancers that are diagnosed in men. The estimated incidence by the American Cancer Society 
for the year 2008 is 186,320 new cases and 28,660 deaths in the United States [(1)].  One of 
the most unique characteristics of prostate cancer is that prostate carcinoma grows indolently 
and can take more than 10 years to turn deadly. At the same time, benign diseases of prostate, 
such as Benign Prostatic Hyperplasia (BPH) and chronic prostatitis, are also very common in 
men over 50 years.  Currently no diagnostic method provides both high sensitivity and 
specificity for prostate cancer detection and characterization. The clinical urological exams 
for prostate cancer rely on Digital Rectal Exam (DRE) and Prostate Specific Antigen (PSA) 
[(2)]. Both provide inadequate and inaccurate information and also suffer from low 
specificity and lack of localization information of the disease. Invasive procedures such as 
TRans-rectal UltraSound (TRUS)[(3)(4)] guided biopsy are implemented to provide a 
definitive diagnosis, which causes discomfort and doesn’t rule out the tumor's existence. 
Diagnostic imaging methods currently in use, such as X-ray CT, Magnetic Resonance 
Imaging (MRI) etc., offer exquisite anatomical details, but generally still suffer from poor 
specificity in detecting cancer in the prostate [(5, 6)]. Low specificity may lead to over-
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treatment, cause great anxiety to patients, and many unnecessary biopsies. But if the patient 
chooses watchful waiting for prostate status, unfortunately, because of the indolent nature of 
prostate cancer, malignant cells have metastasized to the other parts of the body before the 
cancer becomes evident.  Thus more sensitive and specific non-invasive tests are needed. 
Therefore, the differentiation of benign diseases from malignant prostate cancer is an 
important issue clinically and medico-economically.  
Magnetic Resonance Spectroscopy (MRS) is a noninvasive and powerful technique, 
which employs magnetic resonance techniques to obtain localized biochemical information 
quantitatively. MRS provides metabolic information about healthy and pathologic tissue to 
supplement morphologic information by MRI or other imaging modalities. In vivo MRS also 
has the potential to distinguish lesions, which may have similar imaging features but with 
different pathological processes.  An MRS study is a safe procedure because radioactive 
tracers are not used and there is no exposure to ionizing radiation. As a result, MRS has been 
extensively utilized in clinical diagnosis, treatment follow-up, cancer staging and recurrence 
monitoring etc in the last decade. Applications in human brain, prostate, breast and other 
human organs have been reported using one-spectral dimensional (1D*) 
1
H MRS and multi-
voxel chemical shift imaging (CSI)[(5-7)].
 1
H 1D* multi-dimensional CSI provides multi-
regional analyses, which is very useful for most multi-focal diseases. Changes in metabolite 
levels in pathological tissues compared with normal tissues have been demonstrated.  
MRS can provide a biochemical ‘fingerprint’ of the prostate. Several different 
metabolites in the prostate, whose levels are altered in prostate cancer, can be detected by 
using 
1
H MRS for spectroscopic assessment. Choline, creatine, polyamines, and citrate are 
the metabolic peaks relevant to prostate cancer [(7)]. The resonances for choline, creatine, 
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polyamines, and citrate occur at distinct frequencies (approximately 3.2ppm, 3.04ppm, 
3.1ppm and 2.6 ppm, respectively) or positions in the spectrum. In healthy prostate tissue, 
citrate is secreted by the epithelial cells of the prostate in large amounts along with high 
levels of zinc, which inhibit the oxidation of citrate in the Krebs cycle. When in the presence 
of cancer, the citrate level is dramatically diminished due to significant reduction of zinc in 
the cancerous epithelial tissue. Concurrently, the choline level is usually elevated due to 
increased cell membrane turnover in the proliferating malignant tissue. The creatine peak 
remains constant in healthy and cancerous tissue. Creatine is incorporated into the ratio only 
because it is close to choline residue and polyamine resonances and cannot be resolved 
separately. The (Choline + Creatine)/ Citrate ratio is usually used as the criteria for the 
diagnosis of prostate cancer in 
1
H 1D* MRS studies.  Although this ratio has been 
historically called the CC: C ratio, it must be kept in mind that it also includes polyamines.   
Polyamine spermine [(8-10)], which is identified as a new promising biomarker for 
prostate cancer, plays an important role in cell proliferation and differentiation. It may 
provide additional information for early diagnosis and prognosis predicting tumor 
progression. It also might be used as a target for chemoprevention or chemotherapeutic 
intervention [(11)]. Recently, Shukla-dave et al [(12)] incorporated the polyamine level into 
their scoring systems for prostate cancer detection by using 1D 
1
H MR spectroscopy, their 
preliminary results showed that polyamine had a better performance on cancer detection than 
did the (Choline + Creatine)/Citrate ratio. However, polyamine levels were only assessed 
qualitatively in their study because of the proximity of the (choline, creatine and polyamine) 
peaks and limited spectral resolution, not allowing the polyamine level to be integrated from 
the overlapping peaks and quantified accurately. 
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 One of the most significant limitation of the 1D* (spectral dimension) 
1
H MRS spectrum 
is its severe spectral overlap because of low spectral dispersion at clinically used field 
strength (B0 <= 7T). Low spectral dispersion causes a large number of metabolites 
contributing to the small range of proton (
1
H) spectra (0ppm~5ppm) overlap [(13)]. 
Consequently, it makes the unambiguous assignment and quantification of metabolites very 
challenging. Another big difficulty is the low metabolite concentrations in biological systems, 
which make the signal to noise ratio (SNR) a critical factor to obtain good-quality results. 
Other MRS techniques include spectral editing and multi-quantum techniques. Spectral 
editing techniques [(14)] are generally optimized for detecting one specific metabolite, thus 
not suitable for simultaneously detecting a large number of metabolites. In clinical studies, 
the available imaging time is very limited.  As a result, in order to simultaneously detect all 
the related metabolites, spectral editing is not a suitable tool for clinical practice if multiple 
metabolites need to be monitored. The major drawback of the multi-quantum MRS technique 
[(15)] is its reduced signal strength (low signal sensitivity).  
In order to address this limitation, various multi-dimensional techniques have been 
developed to overcome the poor spectral resolution of 1D* spectroscopy of bio-
macromolecules. Multi-dimensional MRS usually enables a larger number of resonances to 
be observed, offering the display of a full spectrum. The applications of 2D* 
1
H MRS 
methods have been investigated mainly because they are expected to provide better spectral 
resolution than 1D* 
1
H MR Spectroscopy and a more efficient and accurate identification 
and quantification of metabolites. Localized 2D* spectroscopy has been used in clinical 
practice for studying normal brain [(16-18)], intra-cerebral tumors [(16)], and breast cancer 
[(19)]. 
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The cross-peaks of metabolites provided by 2D* 
1
H MRS spectra such as polyamine 
contain information on the concentration of these compounds. In general, in a crowded 
1
H 
MR spectrum, the additional resolution provided by the 2D* COSY experiment may allow 
one to monitor the concentration of several compounds simultaneously. Therefore the 
concentration time course of specific compounds can be monitored by following the time 
course of the volume of their cross peaks. The specific effectiveness of 2D* 
1
H L- COSY 
sequences for monitoring important biomarkers which are difficult to determine from 1D* 
spectra, has led to various applications to the pathological processes where these molecules 
are particularly relevant. This technique can be used to investigate the metabolism of 
biomarkers in various physiological states and to study the effects of drugs and different 
models of disease metabolism [(20)].  
Due to the heterogeneous aggressiveness and multi-focal nature of prostate cancer, 
single-voxel localization MRS may fail to identify the target lesion in prostate cancer. And 
the partial volume effect will further worsen the situation. Therefore, multi-regional MRS 
analyses are recommended to improve the sensitivity of detection and extensive assessment 
of tumor extent. 
 
1.2 Objective 
 
The main goal of the current work was to develop a new technique that would not only 
resolve the overlapped 1D* 
1
H MR spectra, but would also be able to separate the spectra 
from spatially separated volumes or multiple contiguous volumes with relatively higher 
signal to noise ratio (SNR), shorter acquisition time and less voxel bleeding [(21, 22)] 
compared to traditional multi-voxel 1D* 
1
H CSI technique.  
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N-dimensional (ND*) Hadamard radiofrequency encoded multi-voxel MRS provides an 
effective way to overcome these problems if simultaneous excitation of a small number of 
voxels is needed. This technique can decrease the voxel-bleeding of the excited voxels and 
leads to well-resolved spectra from the individual voxels. Higher signal to noise (SNR) ratio 
and relative short scan time can be gained compared to traditionally gradient encoded multi-
voxel MRS.  
        Toward this objective, ND*-Hadamard multi-voxel water-suppressed 
1
H MR 
spectroscopy was developed for the ultimate goal of accurate in vivo quantification of 
1
H 
metabolites of prostate. The development of this new technique requires a thorough 
understanding of the multi-frequency excitation RF pulse waveform, pulse sequence 
programming of MRI/MRS system, Hadamard encoding/decoding scheme [(23, 24)] and the 
principle of two-spectral dimensional NMR spectroscopy. This new technique allows for 
acquisition data from simultaneously excitation of multi-volumes. Another advantage of this 
Hadamard 2D* localized COSY is that it allows contra-lateral and heterogeneous tissue 
comparisons.  
In order to obtain unequivocal identification and assignment of metabolites, two most 
popularly used 2D* MRS techniques: single-voxel 2D* Localized J-resolved Point 
REesolved SpectroScopy (JPRESS) [(25)] and single-voxel 2D* Localized COorrelated 
SpectroscopY (L-COSY) were implemented, and their capability in resolving the prostate 
metabolites such as polyamine spermine, citrate, choline, lactate was compared. The strategy 
about how to improve the detection and monitoring prostate cancer progression was also 
discussed.  
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1.3 Scope  
 
In the study, multi-volume 
1
H MRS was implemented to improve the volume coverage 
and has the flexibility of allowing voxel shifting for correlation with MR images and 
histology. An MR protocol that includes optimized sequences of multi-voxel 2D* localized 
MR COSY MR Spectroscopy for the purpose of detecting metabolites specific for prostate 
cancer was performed on a 4T whole body MR scanner. 
 2D* MR spectra were obtained from the prostate phantom in order to discriminate 
spermine (one of polyamine compounds) from the neighboring creatine and choline 
compounds. Comparisons between single-voxel 2D* Localized COSY and single-voxel 2D* 
Localized JPRESS were performed and evaluated on their abilities of detecting citrate and 
polyamines and other metabolites of prostate.  
Hadamard multi-voxel 2D* L-COSY 
1
H MR spectroscopic technique was performed on 
the prostate phantom and individual metabolite phantoms to show the accuracy of the volume 
selection and the spectral quality. Therefore, development of imaging methods is also one of 
the important parts of this project. The experimental results demonstrate the accurate 
selection of the Hadamard multi-voxel 
1
H MR imaging/spectroscopic technique.  
 
1.4 Summary of Contents 
 
A literature review of one-spectral dimensional (1D*), two-spectral dimensional (2D*) 
magnetic resonance spectroscopy application of prostate cancer and the significance of the 
study is given in the following chapter. The background and the basic theoretical concepts 
about 1D*, 2D* L-COSY and 2D* JPRESS are summarized in Chapter 3. In Chapter 4, the 
single-voxel 2D* L-JPRESS MRS technique was implemented to compare with the 2D* L-
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COSY technique. The advantages and disadvantages of both techniques are thoroughly 
investigated. In Chapter 5, the mathematical basis and development of Hadamard RF pulses 
are introduced in details. Computer simulation and experimental results for simultaneous 
multi-slice excitation using Hadamard multi-frequency composite RF pulses are described. In 
Chapter 6, the combination of Hadamard encoding scheme and 2D* 
1
H Localized COSY 
sequence capable of multi-voxel localization is introduced. The details of pulse sequence, 
experimental procedure setup, data analysis and results are also discussed. The last chapter 
concludes with a summary of benefits and contribution of this dissertation and a discussion 
of future research work. 
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Chapter 2 
 
Literature Review of MRS Application of Prostate Cancer 
 
 
In the United States, prostate cancer is the second leading cause of cancer mortality in 
males. Compared to most other malignancies, prostate cancer is an increasingly complicated 
and controversial issue due to its unique characteristics. It usually occurs late in age, has 
relatively slow multi-stage progress, and is frequently diagnosed at lower-stage causing over-
treatment and complications. Many prostate cancers are indolent, and take more than 10 
years to become life threatening. These particular characteristics of prostate cancer result in a 
high incidence-to-mortality ratio.  
 
2.1 Current Diagnostic Methods of Prostate Cancer 
 
2.1.1 Current Urologic Exams 
 
Currently, the differentiation of benign and malignant disease of the prostate is still 
limited if only based on standard urologic examinations. The screening diagnostic techniques 
for prostate cancer include Digital Rectal Exam (DRE) and Serum Prostate Specific Antigen 
(PSA). PSA has substantially improved early detection of prostate cancer in the last two 
decades. But both methods provide inadequate and inaccurate information, and the 
specificity and sensitivity of DRE exams rarely exceed 50% [(1)]. PSA tests [(1)] cannot 
differentiate prostate cancer from benign conditions such as chronic prostatitis or BPH, and it 
does not provide localization information of prostate cancer. TRans-rectal UltraSound 
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(TRUS) [(2)] has been widely used for TRUS guided prostate needle biopsies and detecting 
prostatic diseases. However, the diagnostic value of TRUS biopsy is limited by the 
inadequate information provided by TRUS biopsy, the invasiveness of this approach, and 
occasional complications caused by this disease. Furthermore, because of the multi-focal and 
highly variability of the prostate cancer, some malignant tumors are easily overlooked. TRUS 
biopsy does not rule out the presence of cancer.  
 
2.1.2 Current Imaging Methods 
 
2.1.2.1 Computed Tomography (CT), In-ProstaScint SPECT and 18FDG PET 
 
With the help of intravenous iodinated contrast media, Computed Tomography (CT) [(3)] 
still lacks delineation between benign and malignant tissue in both contrast-enhanced CT 
images and un-enhanced CT images. For In-ProstaScint

 SPECT/CT technique [(31)], if it is 
used alone, it has the limitations in assessing the patient undergoing clinical management. 
While combined with MRI/MRSI, it can help to improve the sensitivity for detection of 
distant lymph node metastases and also is more sensitive when the patient is undergoing 
androgen deprivation therapy and therefore provides useful diagnostic information, which is 
not readily available from the MRI/MRSI study alone. 
Currently, the most popularly used molecular imaging technique in body imaging is 
fluorine 18 fluoro-deoxyglucose (
18
FDG) Positron Emission Tomography (PET). 
18
FDG PET 
[(3)] is prevalent for the staging and restaging of many of the most common cancers such as 
lung cancer, breast cancer, and colorectal cancer etc. However, 
18
FDG PET shows 
considerably lower sensitivity for detection of prostate cancer compared to other 
conventional imaging techniques for staging due to the characteristics of prostate cancer, 
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which is indolent most of the time, lack of aggressiveness, the corresponding decreased level 
of glycolysis of low-grade prostate cancer, and its proximity to the bladder. 
 
2.1.2.2 Magnetic Resonance Imaging of Prostate Cancer 
 
High-resolution MR images are widely used to provide exquisite morphological 
information for initial diagnosis of prostate cancer following standard diagnosis methods. 
MR images allow evaluation of extra-capsular extension and seminal vesicle invasion of 
tumors. This not only can help the local staging, but also helps surgeons and radiation 
therapists plan appropriate treatment correspondingly. On T2 weighted MR images, prostate 
tumor usually shows decreased signal intensity as compared to surrounding high-signal-
intensity healthy prostate tissue [(4)]. However, the reduction in MR signal intensity, which 
is due to a loss of normal glandular (ductal) morphology in regions of prostate cancer, also 
present in several benign pathologies with hypo-intensity the same as prostate cancer, thus 
considerably lowers the specificity of cancer detection by using MR imaging alone. 
 
2.2  Magnetic Resonance Spectroscopy Study of Prostate Cancer 
 
2.2.1 Single-Voxel 1D* 1H MRS 
 
1
H 1D* MRS is a non-radioactive, non-invasive technique, which is capable of producing 
biochemical information quantitatively about a large number of cellular and extra-cellular 
small molecular markers, such as metabolites, polypeptides and lipid, in the living body. The 
metabolism of chemicals of normal and pathological tissue can thus be extracted. 
Biochemical changes explored by in vivo MR Spectroscopy studies can serve as biomarkers 
for different diseases, hence facilitate the diagnosis and monitoring of the disease in response 
 14 
to treatment. In addition, characterizing the status of bio-chemicals in diseases may increase 
the understanding of the pathogenesis of cancer. Functional MR technique by using 
1
H MR 
Spectroscopic Imaging (MRSI) is a novel approach that can improve the characterization of 
prostate cancer in patients prior and after therapy [(5, 6)]. The term ‘virtual biopsy’ has been 
created to refer to the ability of MRSI to provide non-invasive tissue characterization of 
tumors. Interest in this technique has been driven by the need to map functional 
characteristics of tumors non-invasively. 
As for prostate cancer, MRS provides a biochemical “fingerprint” of the prostate gland. 
Several different metabolites in the prostate such as citrate [(7, 8)], choline and polyamine, 
whose levels are altered in prostate cancer, can be detected by using 
1
H MRS for 
spectroscopic assessment. (choline + creatine)/ citrate ratio is usually used as a criterion for 
the diagnosis of prostate cancer in 
1
H 1D* MRS studies.  In healthy prostate tissue, citrate is 
secreted by the epithelial cells of the prostate in high levels while in the presence of prostate 
cancer, the citrate level is dramatically diminished. The choline level is usually elevated due 
to increased cell membrane turnover in the proliferating malignant tissue. The creatine peak 
remains constant in healthy and cancerous tissue. Creatine is included in the ratio only 
because it is close to the choline residue and polyamine resonances, and cannot be resolved 
separately. The MRS spectra data for the four main biomarkers can be turned into a color-
coded map, which can be overlaid on the MR image to visualize the chemical hot spots or 
areas of concern.  
Still there remain some confounding factors, which affect the accuracy of the 
measurement of (choline + creatine)/citrate ratio. The citrate level not only decreases in 
prostate cancer, but also decreases in prostatitis, post-biopsy hemorrhage and prostatic 
 15 
atrophy, which causes false positives in benign cases. Strong coupling of citrate induces 
echo-time-dependent J-modulations of the resonances, which differs considerably with field 
strength. Small tumors surrounded by healthy tissues produce significant partial volume 
effects. Furthermore it is difficult to detect the small lesion due to the small metabolic 
changes especially for infiltrative tumors and early-stage pathological tissues. New 
biomarkers are needed to improve the accuracy of diagnosis and sensitivity. The use of 
newer metabolic markers like polyamine spermine may potentially provide a more sensitive 
and accurate spectroscopic evaluation of the progression and recurrence of the disease.  
 
 
Figure 2.1 shows 600MHz (14T) NMR spectra from 260mg fresh prostatic biopsy material in PBS (pH 7.2). 
From the spectra, the severe spectral overlap is shown between choline (3.2ppm) and creatine (3.0ppm) as there 
are multiplet polyamines (3.05ppm~3.15ppm) between them and they are often difficult to be resolved. For 
other metabolites, we can see the overlap of lactate with lipid/choline, Glx with spermine at 2.1ppm, multiplet 
spermine overlaps with choline, creatine at 3.0to 3.2ppm. Inositol and total choline are overlapped at several 
peaks. Magnetic Resonance Materials in Physics, Biology and Medicine 10(2000) 153–159 
 
2.2.2 Multi-Dimensional Magnetic Resonance Spectroscopic Imaging (MRSI) 
 
 16 
MRS provides biochemical and metabolic information associated with tumor growth and 
development. Both single voxel and multi-voxel add far more information to the diagnostic 
process than conventional MRI. It enables the study of prostate metabolites non-invasively.  
 The combination of Magnetic resonance imaging (MRI) and MRSI offers both detailed 
anatomic and metabolic estimation of the prostate gland. MRSI is rising as a useful technique 
for local assessment of prostate cancer extent and aggressiveness. It is a unique method, 
which can offer both normal and altered tissue metabolism, and is therefore different from 
other imaging methods that only evaluate abnormalities of structure. 
 It was reported that multi-dimensional MRSI was able to detect more foci of prostate 
cancer than MRI, TRUS, and TRUS-guided biopsy prostate based on citrate, creatine, and 
choline measurement. 
 
2.2.3 The Role of MRS and Multi-Dimensional MRSI for Cancer Study 
 
2.2.3.1 Localization, Detection and Staging 
 
Instead of being used as a primary diagnostic technique for cancer detection, the role of 
MRI in prostate cancer has mainly been for staging, or assessing the extent of disease. The 
addition of 
1
H MRSI to MRI contributes to improve prostate cancer localization, detection, 
evaluation of tumor volume, and the extra-capsular extension, which makes the diagnosis 
more accurate and decreases the inter-observer variability. And it also indirectly improves 
local staging. 
Several studies showed that 
1
H MRSI metabolic and volumetric data correlate with 
pathological Gleason grade [(9)]. This implies that it may offer a non-invasive method to 
better predict prostate cancer aggressiveness. The additional metabolic information obtained 
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from 
1
H MRSI helps to improve the prediction of cancer extent, thus can assist in treatment 
planning (including surgery or radiotherapy), therapeutic monitoring, post-treatment 
evaluation, and cancer recurrence detection. Based on this information, it may reduce the rate 
of false-negative biopsies and therefore decrease the need for more extensive biopsy 
protocols and multiple repeat biopsy procedures, which can considerably decrease the 
discomfort of prostate cancer patients.  The use of higher magnetic field scanners has enabled 
higher spatial resolution MRSI data, which increases the sensitivity of MRSI to smaller 
cancers. Combining high resolution anatomic (MRI) and metabolic (MRSI) imaging data 
with other clinical data has proven to be useful in selecting the most appropriate therapy for 
individual patients and in determining the effectiveness of therapy.   
       
2.2.3.2 Providing Metabolic Information For Radiation Treatment 
 
The new trend of treatment is the advent of ‘active surveillance’ of tumor and focal 
ablative therapy such as interstitial brachytherapy, intensity-modulated radiotherapy (IMRT), 
high-intensity focused ultrasound (HIFU) and cryosurgery.[(10)]. As we mentioned before, 
the important characteristics of prostate cancer are its multi-focal, heterogeneous nature and 
the presence of different clusters of aggressiveness within the same tumor volume. Several 
results of clinical trials have implied prostate radiation dose is very important. A suitable 
increased radiation dose may increase local control rates and decrease the risk for distant 
metastasis and thus decrease overall mortality rate. However, a too high dose may cause 
increased morbidity. Therefore, instead of treating the whole prostate gland with a 
homogeneous high-dose level traditionally, different radiation dosage should be applied to 
different volumes according to different tumor aggressiveness. 
1
H MRSI is an ideal non-
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invasive tool offering the possibility for controlling tumor-targeted therapy, which provides 
the metabolic functional mapping of cancerous prostate gland non-invasively. The new 
imaging and spectroscopy techniques are capable of mapping tumor volume or localizing 
more aggressive regions within the tumor, such as highly proliferating or hypoxic foci. These 
features not only make the implementation of advanced therapeutic techniques possible and 
efficient, but also substantially reduce the morbidity associated with treating the entire 
prostate, whether by radiation or surgery. 
 
2.2.3.3 Monitoring Patient After Therapy And Recurrence Detection 
 
Conventional imaging methods including TRUS, CT, and MRI, often lack the ability to 
differentiate healthy from malignant tissue after therapy owing to therapy-induced 
morphological changes in tissue structure [(3, 4, 6)]. So far, the golden standard to determine 
whether the residual or recurrent tissue is malignant is still the histological analysis of 
random biopsies, which is prone to sampling errors, is more difficult to interpret 
pathologically after therapy and also causes anxiety and discomfort to the patient. Several 
MRI/MRSI studies of prostate cancer have also demonstrated its ability to differentiate 
residual or recurrent prostate cancer from residual benign tissue, hormone deprivation 
therapy and radiation therapy [(10)]. 
 
2.3 The Importance of Detection of Polyamine Using 1H MRS 
 
2.3.1 Polyamines May Improve The Detection of Prostate Cancer—New Biomarker 
 
 The polyamines which include putrescine, spermidine, and spermine are polycationic 
amines that are present in most living organisms and are important physiological markers. 
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Polyamine spermine levels were reported to decrease to a very low level in human prostate 
cancer tissue whereas levels of the spermine were high in normal prostate tissue and Benign 
Prostate Hyperplasia (BPH). As we see in Fig 2.2, comparing the three polyamines, the 
concentration of spermine is the highest and it showed the largest variation. Spermine was 
shown elevated in BPH but dramatically reduced in prostate cancer. These observations 
indicated that direct measurement of polyamine spermine maybe a valuable diagnostic tool to 
discriminate prostate cancer from benign hyperplasia and normal prostate. For this reason, 
polyamines have been suggested as biomarkers of prostate cancer progression [(11-13)] and 
the levels of polyamines should be monitored to determine the progression of disease. Since 
polyamines are ubiquitous and essential for cell survival, efforts also have been attempted to 
inhibit polyamine synthesis to reduce the cycling of highly proliferative cancer cells.  
 
Fig 2.2 Average polyamine concentrations (nmol/mg protein) with standard deviations in various prostatic 
tissues as determined by HPLC. * P<0.05, ** P<0.01 compared with control (NP). NP, Normal prostate; BPH, 
benign prostatic hyperplasia; PCa, prostate cancer; PCa Met, prostate cancer with metastases; PCa Xen, human 
xenograft models of prostate carcinoma. Magnetic Resonance Materials in Physics, Biology and Medicine 
10(2000) 153–159. 
 
Therefore, when collecting additional data including another metabolite biomarker, 
polyamines, need to be considered to increase the accuracy for detecting prostate cancer. The 
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role of polyamines has been investigated in several studies in cellular growth and 
differentiation in prostate cancer [(11, 12)]. In vitro MR spectroscopic studies have revealed 
that a high content of polyamine spermine is present in normal and benign hyperplastic tissue, 
while polyamine spermine levels in malignant tumors are markedly reduced [(13)].The 
polyamine spermine itself, which plays a role in cell proliferation and differentiation, may 
provide additional information for early diagnosis and prognosis predicting tumor 
progression. The incorporation of PA information into human prostate spectral interpretation 
has been reported.  Some researchers [(14, 15)] started to incorporate polyamine spermine, 
which is dominant in human prostate, as an additional biomarker in their detection of prostate 
cancer. Recently, Shukla-dave et.al. [(15)] reported in their preliminary Classification and 
Regression Tree (CART) analysis that incorporation of polyamine into the diagnosis had a 
better performance on the detection of cancer than only using the (Choline + 
Creatine)/Citrate ratio. However, the differentiation of Choline from polyamine is inherently 
difficult because of the proximity of the peaks and the limited spectral resolution available 
within a reasonable imaging time. A distinct integration region cannot be assigned for 
polyamine. Thus, polyamine could not be integrated and quantified. It can be only assessed 
qualitatively and reported relative to the choline peak. 
 
 
2.3.2 Polyamine As A Confounding Factor  
    
Furthermore, another confounding factor for the accurate quantification of (Choline + 
Creatine)/Citrate ratio is polyamine metabolite. The overlap of polyamine multiplet peaks 
with choline in 1D* 
1
H MRS is still severe even at relatively high clinically used magnetic 
fieldz such as the 3T MR scanner.  In the prostate, polyamine spermine has three multiplets 
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at 1.8ppm, 2.1ppm and 3.1ppm~3.15ppm. The 3.05ppm~3.15ppm multiplet peak occurs 
between the creatine and choline peaks and cannot be entirely resolved from these peaks. 
Although this ratio has been historically called the (Choline + Creatine /Citrate) ratio, it 
actually also includes polyamines. This presents a problem when choline is elevated in 
cancer whereas polyamines diminish, which obscures the accurate quantification of both 
metabolites. 
 
2.3.3 Polyamine as a Chemoprevention Agent of Prostate Cancer 
 
 The polyamines, which include putrescine, spermidine and spermine, are essential for 
cellular proliferation.  In the mammalian polyamine biosynthesis pathway, the first of 
polyamine, putrescine, is catalyzed from ornithine by ornithine decarboxylase (ODC). 
Putrescine is converted into spermine by aminopropyl transferase, spermine synthase and a 
second aminopropyl transferase termed spermidine synthase, which adds an additional 
propylamine moiety to spermidine. And ODC has been found to be over-expressed in 
prostate cancer [(25)]. Although the exact physiological role of polyamines is unknown, a 
rise in the activity of polyamine biosynthetic enzymes and an increase in the cellular levels of 
polyamines occur during normal cellular differentiation and growth and in cancer. The 
polyamines spermidine and spermine have been implicated or involved in a wide variety of 
physiologic processes, most of which are closely related to cell proliferation [(27)]. The 
polyamines also bring diverse effects on protein synthesis and act as inhibitors of numerous 
enzymes including several kinases [(27)]. Similar to citrate, healthy prostate epithelial cells 
also contain very high concentrations of polyamines, where spermine is particularly 
dominant [(6,20,25,26)].  Polyamines are considerably reduced in prostate cancer and this 
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reduction is associated with significant changes in the levels of expression of polyamine 
metabolism regulatory genes [(6, 25)]. High levels of spermine are found in the healthy 
prostatic ducts [(26, 28, 29)] and the observed variations of spermine in cancer may be due to 
the loss of ductal morphology or a reduction in the secretion of polyamines [(30)]. 
Pharmaceutically, polyamine might be used as the target for chemoprevention or 
chemotherapeutic intervention. Currently, prostate cancer can be detected earlier, but 
downstaged at the time of diagnosis. The natural slow, indolent progression of this disease 
has made its treatment a complicated and controversial issue.  As many patients choose to 
wait and monitor their prostate status, chemoprevention is a good choice for the prevention 
of prostate cancer development as well as prevention of prostate cancer progression.  Since 
polyamines are important for tumor cell growth, interference with polyamine metabolism 
could provide a promising target for chemotherapy of cancer. Several compounds are able to 
inhibit the action of the enzymes involved in the polyamine biosynthesis. 
Difluoromethylornithine (DFMO), which irreversibly inactivates ODC, is the most widely 
studied example of a polyamine-metabolism inhibitor that suppresses cancer development in 
animal models and has been evaluated in clinical trials. It is an irreversible inhibitor of 
Ornithine decarboxylase (ODC), the rate-limiting step in the conversion of ornithine to 
putrescine and subsequently to the polyamines spermidine and spermine [(16, 17)]. 
All in all, the detection of polyamine not only can be used as a new biomarker to improve 
the diagnosis accuracy, resolve the overlapping spectra but also can be used as a target for 
chemoprevention and chemotherapeutic agent. All these potential research interests about 
polyamines make its accurate measurement very important.  
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2. 4  The Limitation of 
1
H MRS 
 
2.4.1 The Limitation of 1D* 1H MRS 
 
One of the major limitations for 1D* MR Spectroscopy of prostate is the significant 
overlap of metabolites. In MR spectra of prostate, the chemical shift range of related 
metabolites are crowded in a very narrow spectral range, less than 5ppm, which makes the 
detection of these metabolites very challenging. In particular, due to the severe overlaps of 
creatine, polyamines, and choline-containing compounds metabolites, previous in vivo 1D 
1
H 
MR prostate spectra could not differentiate these polyamines from the choline residues in the 
spectral range of 3.0~3.2 ppm, which leads to an ambiguous assignment and quantification of 
metabolite.  One of the ways to increase spectral dispersion (resolution) is to increase 
magnetic field strength. Recent examinations performed at 3T and 7T [(18, 19)] revealed that 
complete differentiation of PA from choline and creatine was still difficult to achieve. In 
order to incorporate polyamine information and (Choline + Creatine)/Citrate into the 
diagnosis procedure, the choline and polyamines level have to be accurately measured. 
 
Fig 2.3  J modulation of citrate and spermine at different TE. (Spectrum data was taken at 4T by using 50mM 
citrate phantom and 50mM Spermine phantom (pH=7.0). 
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Another limitation of 1D* 
1
H MRS is the J modulation of citrate and spermine 
metabolites.  J modulation depends on field strength, sequence timing and sequence diagram. 
The J modulation of citrate and spermine made the quantification of these two metabolites 
not consistent.  The echo time, sequence timing and diagram usually need to be optimized for 
different machine and magnetic fields in order to obtain consistent results. While 2D* MRS 
collects the spectra of metabolites at different TE time, therefore the J modulation of 
metabolites were included in the 2D* spectrum.  
 
2.4.2 The Limitation of Other MRS Techniques 
 
The MRS spectral editing technique, which is based on multi- or zero-quantum filtering 
or on polarization transfer etc, has been employed successfully to solve the overlapping 
problem in 1D MRS. The main drawback is that only one metabolite can be detected in one 
measurement making this technique inefficient and not practical in clinical applications. 
Another solution called multiple-quantum filtered MR spectroscopic sequence also suffers 
from a severe signal loss associated with the facts that only one or two of the coherence 
transfer pathways are chosen to be observed. 
 
2.5 The Significance of The Study 
 
2.5.1 The Advantages of Using 2D* MR Spectroscopy Technique 
 
2.5.1.1 2D* MRS Provide Better Spectral Resolution and More Information of 
  Metabolites 
 
Two-dimensional and multi-dimensional MR spectroscopy techniques are important 
innovations in the NMR spectroscopy field. They opened a door to solve the severe overlap 
problems in the 1D MR spectra.  Applications on phantoms, animals and human beings using 
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different localized and non-localized 2D MRS techniques have been implemented by many 
researchers [(20-22)].  
Because of the added second spectral dimension, a 2D MRS spectrum has better spectral 
resolution than the conventional 1D MRS spectrum. It contains well-resolved cross peaks 
that can be used to measure the metabolic changes in different pathologies.  
 
2.5.1.2 SNR Improvement and Less Voxel Bleeding of Hadamard Technique 
 
The multi-voxel Hadamard spectroscopic technique has the benefits of either reducing 
the voxel size or reducing the data acquisition time or a combination of both owing to the 
improvement of the SNR when compared to single-voxel spectroscopic techniques in a 
similar way as chemical shift imaging (CSI). In general, a N  fold gain in sensitivity is 
obtained for N encoded voxels.  
       Another advantage of Hadamard MRS over CSI is that Hadamard MRS localization 
schemes suffer less from inter-voxel signal leakages, also known as ‘voxel bleed’, which can 
be principally controlled or reduced to noise level [(23)] if properly designed. 
 
Well-resolved Cross-peaks In 2D Spectrum Can Be Used to Monitor Concentration 
of Metabolites 
 
 
The cross peaks obtained by 2D* 
1
H MRS spectra also contain information concerning 
the concentration of that compound. Therefore the concentration time course of a compound 
can be monitored by following the time course of the volume of its cross peaks. The 
additional resolution provided by the 2D* COSY experiment provides the opportunity to 
monitor the concentration of several compounds simultaneously. Therefore the concentration 
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time course of specific compounds can be monitored by following the time course of the 
volume of their cross peaks.  
The specific effectiveness of 2D* 
1
H L- COSY sequences for monitoring important 
biomarkers which is difficult to determine from 1D* spectra, has led to various applications 
to the pathological processes where these molecules are particularly relevant. This technique 
can be used to investigate the metabolism of biomarkers in various physiological states and 
to study the effects of drugs and different models about disease metabolism.  
 
2.5.2 Significance of Using Hadamard Multi-Voxel 2D* Localized MR  
Spectroscopy Technique 
 
Chemical shift imaging (CSI) is a 1D* multi-voxel MR Spectroscopy technique, which 
allows the acquisition of multiple voxels in single or multiple slices. It is a tool that combines 
MRI and MRS producing multi-dimensional anatomic information with concurrent 
acquisition of metabolic processes. This technique is commonly used to examine multi-focal 
diseases, which is very suitable for prostate cancer due to the multi-focal nature of prostate 
cancer.  
Although multi-dimensional (spatial dimension) 1D*(Spectral dimension) CSI has shown 
its ability to distinguish prostate cancer from healthy prostate tissue with relatively high 
specificity, there are several limitations to this method. First, it has the same severe spectra 
overlap problem as 1D* (spectral dimension) MRS. Second, it suffers from voxel bleeding, 
which is an intrinsic problem of this technique; details will be provided in the later chapters. 
Third, the acquisition is usually cumbersome and relatively time-consuming.  
Due to the partial volume effects and low concentration of metabolites in biological 
systems, the SNR is a critical factor for the MRS localized study. Hadamard encoded multi-
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voxel MRS offers an effective way to overcome these limitations if simultaneous excitation 
of a small number of voxels is needed. This technique can decrease the voxel-bleeding of the 
excited voxels and leads to well-resolved spectra from the individual voxel. Higher signal to 
noise (SNR) ratio and relative short scan time can be gained compared to traditionally 
gradient encoded multi-voxel MRS.  
Prostate adeno-carcinoma is also distinctively characterized with multi-focal, highly 
biological variability, and synchronous presence of different clusters of aggressiveness 
within the same tumor volume.  Some of the malignant tumors will be easily overlooked by a 
single-voxel based MR spectroscopy method.  
Therefore, in order to obtain non-overlap spectra information from different areas in the 
prostate, a multi-voxel two-dimensional MR spectroscopic imaging technique within a 
reasonable acquisition time is needed. With the help of Hadamard multi-voxel 2D Localized 
MR spectroscopy technique, a well-resolved 2D* spectrum will be provided, the differences 
in metabolite ratios between tumor and the surrounding normal tissues can be detected, and 
furthermore, the extent of cancer can be better determined 
.  
2.6 Previous 2D* Localized JPRESS and 2D* L-COSY MRS 
 
Two popularly used localized versions of two-dimensional (2D*) MRS sequences include 
2D* JPRESS and 2D* L-COSY etc. 2D* Localized COSY is short for two-dimensional (here 
means two spectral dimension, which is different from two-dimensional spatial volume 
selection) localized spectrum COrrelated SpectroscopY (L-COSY) sequence. 2D* J-resolved 
spectroscopy was demonstrated to be a useful tool for detecting metabolites in the case of 
strong overlap in the chemical shift dimension. A localized version of the 2D* J-resolved 
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MR spectroscopic sequence is JPRESS, which uses the point-resolved spectroscopy (PRESS) 
sequence (JPRESS) for volume localization has been employed recently to exploit its optimal 
sensitivity. Applications of JPRESS have been demonstrated in brain and prostate cancer in 
vivo.  
Kenneth and Marinette et al demonstrated in their applications of localized 2D* JPRESS 
in prostate examinations that, 2D* J-resolved MRS enables the spectral separation of creatine 
(Cr) and Cho from polyamine spermine (Spm). However, the limited spectral resolution 
along the second axis (F1) resulted in an overcrowded 2D* JPRESS spectrum by the 
unavoidable strong coupling effects of Citrate, which produces complex spectra and 
difficulty in interpretation. The complex overcrowded cross-peak pattern of 2D* J resolved 
spectra brings difficulty for the analysis of prostatic metabolites. A localized 2D* L-COSY 
had been implemented at 7T to explore the 2D* COSY spectrum of prostate phantom [(19)], 
which could get a better dispersion of J-cross-peaks for both polyamine spermine and citrate 
at 7T.  
2D* localized COSY spectrum of brain offers a better dispersion of the J-cross-peaks 
compared to the 2D* J-resolved spectra. Different versions of the localized COSY sequence 
have been proposed. Non-localized versions of COSY spectra implemented in animal studies 
using the high field NMR spectrometers and localized 2D* COSY spectra of the phantom 
results were also reported.  Thomas and coworkers have recently implemented a 2D* 
Localized COSY sequence on 1.5T MRI/MRS scanner for brain and breast studies [(21, 24)]. 
It was demonstrated that the 2D* cross peaks due to several J-coupled metabolites recorded 
in human brain and breast cancer were better detected than by the conventional 1D* MRS 
techniques.  
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Chapter 3 
 
Two dimensional Magnetic Resonance Spectroscopy 
Background and Thesis Related Concepts 
       
 
 Generally speaking, the Nuclear Magnetic Resonance (NMR)[(1)] spectrum provides 
information about the spin’s local magnetic field, which is generated by interactions between 
static magnetic field B0 and spin’s circulating electrons, and is also affected by spin-spin 
interactions. Chemical shift creates a local magnetic field, which represents the interactions 
between static magnetic field B0 and electrons. It determines the peak position of the 
resonances, while spin-spin coupling, one of spin-spin interactions, creates the signal 
multiplicity represented as multiplets (triplet or quartet).  Another type of spin-spin 
interaction, i.e. direct dipole-dipole interaction, is characterized by T1, T2 relaxation time 
constants and NOE effects, which usually affect the peak height and line width of the 
resonances. 
 
3.1 Chemical Shift and Spin Coupling 
 
3.1.1 Chemical Shift 
 
Proton spin precesses in the magnetic field B0 at the Larmor frequency ω0. The 
circulating electrons in a molecule surround the nuclei and generate a small local magnetic 
field, which shields the nuclei slightly from the external field B0. Therefore, the Larmor 
frequencies of different nuclei may be different owing to their different chemical 
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environment. This effect is called the 'chemical shift'. It is one of the major concepts of NMR 
spectroscopy since it causes the different magnetic resonance positions of the signals in a 
NMR spectrum. 
 
     
Fig 3.1a. Chemical shift                            Fig 3.1b   Shielding effect.                                                 
 
As shown in figure 3.1a and 1b, Larmor frequency is: πγω 2/00 BH−= , where Hγ is the 
proton 
1
H gyromagnetic ratio, and B0 is the external magnetic field. The external field B0, 
which causes the electrons to circulate, can generate the small magnetic field Belectron as 
follows: 
        electronlocal BBB += 0           (3.1) 
         0BBelectron σ−=      (3.2) 
         00 BBBlocal σ−=             (3.3) 
Different local magnetic fields are responsible for the appearance of different magnetic 
resonance signals in 
1
H NMR spectra. The value of the chemical shift δ is usually defined as 
the difference in resonance frequencies between the nuclei of interest (ν) and a reference 
nucleus (νref). The chemical shift  δ in ppm (parts per million) is defined as follows: 
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ref
ref
ν
νυ
δ
)(106 −
= ppm            (3.4) 
Chemical shift is a dimensionless parameter. ‘ppm’ means parts per million, which comes 
from the factor 10
6
 and it is independent of the magnetic field strength B0. Different chemical 
groups have different chemical shifts. This is one of the important information items coming 
from NMR spectra.  
 
3.1.2 Spin Coupling   
 
Due to the shielding effect caused by motion of electrons circulating in their orbits, the 
resonance frequency of nucleus A is defined as follows: 
νA = -γA B0(1-σA) / 2π           (3.5) 
Where σA is the shielding factor of nucleus A, γA is gyromagnetic ratio of nucleus A, B0 
is the external static magnetic field, and γA is the resonance frequency of nucleus A. In 
addition to chemical shift effect, every spin also creates a small local magnetic field. This 
local field interacts with nearby nuclei either directly (dipole-dipole interactions through 
space) or indirectly (J-coupling through bonds) via molecular electrons. In liquids, the 
dipole-dipole interactions usually average to zero due to the fast Brownian molecular 
motions. Two spins experiencing J-interaction are said to be J coupled. Their interaction is 
controlled by bonding electrons, whose spins are polarized by the nuclear magnetic moments. 
Multiplet splitting is often seen in NMR spectra. This splitting is caused by scalar 
coupling between the protons. Depending on the state of the spin X nucleus (parallel, ↑, or 
anti-parallel, ↓, with respect to B0) the electron’s spin magnetic moment will either increase 
or decrease the local magnetic field on the site of a coupled spin A by JAX /2 Hz. The result is 
splitting of the signal (multiplet) into two halves separated by JAX Hz. The distance between 
 35 
the lines in a multiplet (in Hz) is given by the coupling constant JAX which is independent of 
the magnetic field strength B0. The real frequency of spin A is described as follows: 
∑ ≠−
−−
=
AX AAX
AA
A mJ
B
π
σγ
ν
2
)1(0
  (3.6) 
Where mA is the magnetic quantum number of spin A, γA is gyromagnetic ratio of spin A, and 
JAX  is the spin coupling constant of spin A and spin X. 
 
                          Figure 3.2a. Spin J coupling        
3.2 Coherence Order 
 
Coherences can be classified according to a coherence order p. Transverse magnetization 
is one example. Coherence order p is an integer taking values 0, ± 1, ± 2 ... Single quantum 
coherence has p = ± 1, double has p = ± 2 and so on; z-magnetization, and zero-quantum 
coherence have p = 0. Different coherences respond to a rotation about the z-axis.  
Coherence transfer can be done through three different ways: through bonds (scalar 
coupling), through space (dipolar coupling) or through physical or chemical exchange. If one 
coherence of order p is transferred to a coherence of order p' by a radiofrequency pulse, the 
phase of the RF pulse will affect the phase of the coherence. It is on this principle that the 
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phase cycling method is based. Defining ∆p = (p' – p) as the change is coherence order, 
whixh simplifies to 
       )()(
'
)exp()exp( ppjz
p
z eFjFj σφσφ
φ ⋅=−− ∆−     (3.7) 
 A coherence of order p, represented by the density operator σ
(p)
 evolves under a z-
rotation of angle Φ According to where Fz is the operator for the total z-component of the 
spin angular momentum. (i.e., a coherence of order p experiences a phase shift of - ∆pΦ), 
equation (3.7) says that if the phase of a pulse, which is causing a change in coherence order 
of ∆p is shifted by Φ, the coherence will acquire a phase label (–∆p). This property enables 
us to separate different changes in coherence order from one another by altering the phase of 
the pulse. 
By varying the MR Spectroscopy signal, we have control over the phase of 
radiofrequency pulses, which excite the spins and receiver phase.   
 
3.3 Coherence Selection: Phase Cycling and Gradient Pulses 
 
 The pulse sequence used in an NMR experiment is carefully designed to select a 
particular coherence. For example, we may want to pass the spins through a state of multiple 
quantum coherence at a particular point, or plan for the magnetization to be aligned along the 
z-axis during a mixing period. However, it is usually the case that the particular coherence 
produced by the pulse sequence we designed is only one out of much possible coherence 
created.  
In general, an RF pulse causes coherences to be transferred from one order to one or 
more different orders. Due to this spreading of coherence, it is necessary to select one 
coherence transfer among many possibilities. Each time a radiofrequency pulse is applied, 
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there is possibility for the coherences branching into many different pathways. For example, 
a radiofrequency pulse applied intending to generate double-quantum coherence from anti-
phase magnetization may also generate zero-quantum coherence or transfer the 
magnetization to another spin.  If these unwanted pathways are not suppressed, the presence 
of such resonances may lead to extra spectral crowding, obscuring the required peaks and 
possibly leading to ambiguities in interpretation. Thus it is very essential to ensure that the 
resonance peaks seen in the spectrum are just those we planned to generate when the pulse 
sequence was designed in advance.  
 
3.3.1 Phase Cycling 
 
Two general procedures are routinely used to choose a particular coherence pathway 
from many possibilities. The first is phase cycling. In this method the phases of the pulses 
and the receiver are varied in a systematic way so that the coherences from the desired 
pathways are included and coherences from all other pathways are cancelled out. The 
experiments usually needs to be repeated several times by phase cycling in order to acquire 
the required signal-to-noise ratio and to choose a particular coherence. 
 
3.3.2 Gradient Pulses 
 
Another selection procedure is to use gradient pulses. By employing gradients in short 
periods during which the applied magnetic field is made inhomogeneous, any coherence 
presenting dephase will be lost. However, this dephasing can also be undone by applying a 
subsequent equal gradient to refocus the exact coherence. This dephasing and rephasing 
method can be used to select particular coherences. The advantage of using gradient pulses 
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for coherence selection over phase cycling is that it does not require repetition of the 
experiment, which saves time. 
 
3.3.3 Coherence Transfer Pathway 
 
A convenient and powerful way of doing the selection is to use the coherence transfer 
pathway approach. Both of these coherence selection procedures can be applied in a unified 
framework, which classifies the coherences presenting at any particular point according to a 
coherence order and then uses coherence transfer pathways to specify the experimental 
designed outcome. The coherence transfer pathway must start with coherence order p = 0 as 
this is the order to which equilibrium magnetization (z-magnetization) belongs. Furthermore, 
the pathway has to end with |p| = 1 since only single quantum coherence is observable.  
 
3.4 One and Two dimensional MR Spectroscopy  
 
3.4.1 The Basic 1D* Experimental Procedure 
 
        
Fig3..3 Basic structure of one spectral dimensional (1D*) experiment 
The one-dimensional NMR experiment consists of two parts: preparation and detection. 
Preparation sets the spin system to a defined state. The resulting signal is detected during the 
detection period. Figure 3.4 illustrates a simple case. A 90° RF pulse rotates the equilibrium 
magnetization Mz onto the transverse x-y plane creating the transverse magnetization Mxy. 
After this pulse, each spin is precessing at its own Larmor frequency ω0i around the z-axis 
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and induces a detectable signal in the receiver coil. The signal usually decays due to T2 
relaxation (one of dipole-dipole interaction) and is called free induction decay (FID).  
 
3.4.2 The Basic 2D* Experimental Procedure 
 
3.4.2.1  The Limitation of 1D* NMR spectra 
 
Fig 3.4   An example of 1D* proton spectra 
Figure3.4 shows a 1D* (spectral dimension) proton (
1
H) spectra, which is very complex 
for interpretation since most of the resonance signals heavily overlap with each other. A 
major leap in NMR spectroscopy apart from the introduction of Fourier Transform NMR is 
the introduction of additional spectral dimensions, which create more simplified NMR 
spectra, thus allowing more information to be obtained.  
 
3.4.2.2 The Basic Structure of 2D* NMR 
 
 
Fig 3.5. Basic structure of 2D* NMR experiment         Fig 3.6. Non-localized Homonuclear Correlation spectroscopy (COSY) 
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3.5 Correlation via Spin Coupling-COSY Technique 
 
         
 
 
 
 
 
 
 
                      
     
Fig 3.7 Correlation via spin coupling (two spins system) 
  
 
 
 
 
 
 
 
 
                                   
 
Fig 3.8   Typical 2D * COSY spectrum 
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Two–dimensional NMR spectroscopy sequence usually includes four time periods: 
preparation, evolution, mixing and detection. 2D* COSY is two-dimensional COrrelated 
SpectroscopY (COSY).  Figure3.6 shows the simplest COSY sequence. During preparation, 
the spins are at an equilibrium state. After the first 90° RF pulse, the spins then evolve during 
the variable delay period t1. In other words, they precess under the influences of both 
chemical shift and mutual spin-spin coupling (which also called J-coupling). This precession 
modifies the signal that we finally observe during the acquisition time t2.   
Spin I and S are excited with the first 90° RF pulse. Both spins are labeled with their own 
Larmor Frequency. During t1 period, if spins are scalar coupled, the signal encodes this 
information as well. The second 90° RF pulse exchanges magnetization between spins I and 
S. Therefore, spin I now has memory of spins S and vice versa. The signal is acquired in t2 
period. Cross-peaks appear between spins, which are scalar coupled (assignments). The 
cross-peak fine structure contains information on scalar coupling. Bilinear interactions, 
namely J-coupling, are unaffected by the refocusing pulse, leading to J-modulation of the 
magnetization during TE. 
In figure 3.6, following the evolution period, a second 90
o
 pulse is introduced. This 
constitutes the next essential part of the sequence, the mixing period. The mixing pulse has 
the effect of distributing the magnetization among the various spin states of the coupled 
nuclei. Magnetization that has been encoded by chemical shift during t1 can be detected at 
another chemical shift during t2. i.e. magnetization is transferred from the first nucleus to a 
second one during the mixing time. Mixing sequences utilize two mechanisms for 
magnetization transfer: scalar coupling or dipolar interaction. Data are acquired at the end of 
the experiment (detection, often called direct evolution time). During this time the 
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magnetization is fingerprinted with the chemical shift of the second nucleus. Two-
dimensional Fourier Transform FT yields the 2D* spectrum with two frequency axes. If the 
spectrum is homonuclear (signals of the same isotope (usually 
1
H) are detected during the 
two evolution periods), it has a characteristic topology. The pulse sequence for a COSY 
experiment contains an incremental delay time t1 and an acquisition time t2. The experiment 
is repeated with different delay times t1, and the data collected during the acquisition t2 are 
stored in the computer. The value of the delay time is increased by regular small intervals for 
each experiment, which should be optimized according to different spin systems, so that the 
data that are collected consist of a series of FID patterns collected during acquisition, each 
with a different value of delay time. 
 
3.5.1 2D* Localized COSY 
 
Figure 3.9 shows a localized two-dimensional shift correlated MR spectroscopic 
sequence (L-COSY) used by Thomas et.al. in  a brain study[(2)]. 
 
               Fig 3.9 2D L-COSY sequence diagram. M. Albert Thomas, MRM 46:58–67 (2001). 
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3.5.2 2D* L-COSY Theory  
 
To evaluate the efficiency of the volume selection –the CABINET method, a single spin 
system, is assessed first. 
 
3.5.2.1 Efficiency of CABINET Volume Selection 
 
For single spin I = 1/2, before the first slice-selective 90° RF pulse, the spin-state is in 
equilibrium  
zI∝0σ          (3.8) 
The first 90° RF pulse along readout direction X will rotate the magnetization in to the X-Y plane, which is 
the transverse plane along –Y axis. 
yI−∝1σ         (3.9) 
During the evolution period, the second 180° RF pulse is flanked by a pair of B0 crusher 
gradient pulses to crush the unnecessary coherences, the 180° RF pulse flipped the fanned  
out magnetization, refocused the diverged magnetization back to +Y axis and formed a spin-
echo  
yI∝2σ        (3.10) 
The spin precesses in the transverse plane and before the third 90° RF pulse the 
magnetization is  
          113 sincos θθσ xy II −∝         (3.11) 
Where               ∫∆= 101 2 τπγθ dB     (3.12) 
The third 90° RF pulse is sandwiched by another pair of B0 crusher gradient pulses.  The last 
90° RF pulse rotates the Iy into Iz, while Ix remains unchanged. 
Therefore,         (3.13) 
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Since only the magnetization at the transverse x-y plane can be observed, the Iz component 
should be excluded since it won’t be observed. Thus the spin state after the evolution period 
during the last set of B0 crusher gradient pulses will be 
12125 sinsinsincos θθθθσ yx II −−∝      (3.14) 
Where                                          ∫∆∝ 202 2 τπγθ dB        (3.15) 
If the crusher gradients used in the sequence are balanced ( 1θ = 2θ ), equation (3.14) will 
become   
     2/5 yI−∝σ        (3.16) 
By using the identities:     0sincos
2
1 2
0
=∫
π
θθθ
π
d       (3.17) 
2
1
sin
2
1 2
0
2 =∫
π
θθ
π
d              (3.18) 
only 50% of the signal is retained from the volume selected by the CABINET (90°-180°-90°) 
selection. The traditional PRESS sequence (90°-180°-180°) will have 100% sensitivity. The 
50% drop of the CABINET selection is due to the N-type echo selected by the crushers 
gradient pulses (coherence order p = -1is selected). Another half signal is positive  +1 
coherence, which cannot be observed just by CABINET selection and thus needs more 
manipulation. Therefore the CABINET volume localization from the Volume of Interest 
(VOI) only has 50% efficiency. 
 
3.5.2.2 MR Signal Obtained By Two-Dimensional L-COSY 
 
Step by step, the 2D* L-COSY MRS signal will be deduced as follows. Only two weakly 
coupled spin systems are considered here: spin I = ½ and spin S = ½, where I is the spin 
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under consideration while spin S is its J-coupled spin. Product operator formalism was used 
to assess the change of magnetization at different time points of the sequence. 
Before the first 90° RF pulse, the spin state is represented as  
zI∝0σ         (3.19) 
      The first 90° RF pulse along the x direction will rotate the spin I to the transverse plane 
along the –Y axis, and the spin state becomes  
yI−∝1σ       (3.20) 
According to 2D* COSY theory, after the first 90° RF pulse, the evolution period of 2∆ starts. 
Both spins evolve through J-coupling. The chemical shift 
)(
1
Iω  is refocused by the second 
180° RF pulse resulting in an echo 2σ ′ , while J-coupling will not be refocused.  
.    )2(sin2)2cos(2 ∆−∆∝′ JSIJI zxy ππσ      (3.21) 
After 2∆, during the t1 evolution period, considering the chemical shift and J coupling, we 
will have 
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In order to simplify the equation, we define  
)cos()cos( 11
)(
1 JttA
I πω=                          (3.23) 
)sin()cos( 11
)(
1 JttB
I πω=                  (3.24) 
)cos()sin(
)(
JttC
I πω=                         (3.25) 
                        (3.26) 
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Then Equation (3.22) becomes 
)2sin(}22{)2cos(}22{2 ∆−++−∆−−−∝ JDISICBISIAJSIDCISIBAI xzyyzxzyxzxy ππσ    (3.27) 
The second pair of crusher gradient pulses is placed around the last 90° RF pulse. After 
the first ∆′ , the spin state can be described as: 
11111113 cos2sin2cos2sincossincos{ θθθθθθθσ zyzyzxyxxy SIDSIBSIBCICIAIAI −−−−−−∝
11111 sincossincos{)2cos(}sin2 θθθθπθ yxxyzx DIDIBIBIJSID −−−−∆+
)2sin(}sin2cos2sin2cos2 1111 ∆−+++ JSICSICSIASIA zxzyzyzx πθθθθ       (3.28) 
After the rotation by the last 90° RF pulse, the spin state is represented as 
11111114 cos2sin2cos2sincossincos{ θθθθθθθσ yzyzyxzxxz SIDSIBSIBCICIAIAI +++−−−∝
 11111 sincossincos{)2cos(}sin2 θθθθπθ zxxzyx DIDIBIBIJSID −−−−∆−
 )2sin(}sin2cos2sin2cos2 1111 ∆+−−− JSICSICSIASIA yxyzyzyx πθθθθ         (3.29) 
Since there is no observable signal from Iz and 2IxSy, they will be excluded. Therefore, 
after the last crusher gradient pulses ( 2θ ), assuming crusher gradient pulses around the last 
90° RF pulse are balanced, i.e. 1θ = 2θ , the spin state is 
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Equation (3.30) describes the coherence transferred to spin S. A similar equation can be 
calculated for spin S, which transfers coherence to spin I. After data acquisition, the 2D* 
MRS signal can be represented by the following equation: 
)]/exp(1)[/exp()/exp()exp(}){(),( 122212
)(
2521 TTRTtTttiITrttS
I
x −−−×−−= ωσ          (3.31) 
After two-dimensional Fourier transform, the 2D* MR spectrum can be described as follows: 
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 ∫∫= 212121 ),(),( dtdtttsFFS                                                 (3.32) 
From equation [3.32] we can see that both the diagonal and cross-peaks of 2D* L-COSY 
spectrum have mixed phases along the F1 axis. In contrast to the amplitude modulation in 
conventional COSY, the phase modulation in L-COSY is caused by the evolution during the 
B0 gradient pulse before the last 90° RF pulse [(2)].  
 
3.6 2D* J- Resolved Spectroscopy—2D* JPRESS 
 
The first two-dimensional (2D*) J-resolved MR spectroscopy sequence [(3)] was 
developed three decades ago, which is a traditional spin-echo sequence [90°-t1/2-180°-t1/2-
acquire (t2)] acquiring Free Induction Decay (FID). In this sequence, linear interactions such 
as chemical shift, resonance offsets were averaged out at echo time TE and static filed 
inhomogeneity is refocused. The signal only depends on T2 decay if ignoring chemical 
exchange and spin diffusion. By acquiring signal at different TE, the second dimension of the 
spectra is achieved. J coupling, a bilinear interaction, which is not refocused by 180° RF 
pulse, modulates the magnetization during TE. The spin echo J-resolved MRS sequence can 
only localize a slice volume. Based on the PRESS sequence, a three-dimensional (3D) J-
resolved sequence was developed to localize a cubic voxel, which improves the localization 
although the minimum TE is longer. Some of the short T2 metabolites would not be 
appropriately detected. Figure 3.10 shows a 2D* J-PRESS sequence diagram [(4)] based on a 
basic PRESS sequence. This 3D-localized 2D* J-resolved sequence [90°- ∆ -180° - ∆ –t1/2-
180°-t1/2-t2 (Acquisition] is modified based on a traditional PRESS sequence, which enables 
simultaneous increment of the two periods t1/2 before and after the last 180” RF pulse.  The 
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time period ∆ is the minimum duration to apply RF and gradient pulses. All three RF pulses 
are slice selection pulses. 
 
                                                Fig 3.10 2D* J-PRESS sequence diagram 
Consider a set of spins S with different chemical shifts δ and experiencing mutual 
indirect interactions. Assuming weak coupling condition (J coupling constant < chemical 
shift difference), the Hamiltonian depiction of the system is described as follows: 
H ∑∑
≠≠
++=
BA
B
Z
A
ZAB
BA
B
ZB
A
ZA SSJSS ππδπδ 222                                      (3.33) 
For the traditional spin echo J-resolved sequence, from the evolution of the spin system 
under the Hamiltonian, if taking into account the transverse relaxation T2 decay, the signal 
from a spin A is given by: 
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Where t2 is the acquisition time and T2 and 
'
2T  characterize the decay of transverse 
magnetization due to inhomogeneous broadening (1/T2∗ =1/T2 +1/ '2T ). The bandwidth in the 
second frequency (spectral resolution) dimension f1 (the J-frequency dimension) is given by 
1/N1(∆t1), where N1 is the number of t1 increments. 
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The assumption of the Hermitian relation is strictly valid for uncoupled spins and is only 
an approximation for coupled spin. Wrong coupling patterns may be induced by this 
approximation especially in case of a large coupling constant, J, where the phase modulation 
could occur during the acquisition time. In a general 2D* J-resolved spectra, cross-peaks 
produced by each coupled spin-pair represent the magnitude of J-coupling. Therefore, 
additional cross-peaks would be created owing to strong coupling.   
 
3.7 Water Suppression, shimming and SNR 
 
A major concern about in vivo MR Spectroscopy is the necessity to reduce the intensity 
of the water signal selectively and efficiently, because the ratio of 10
5
 between H2O and the 
metabolites is generally a too large dynamic range for the spectrometers to deal with. This 
signal reduction can be made by selective saturation of water [(12)]. 
The Chemical Shift Selective Saturation (CHESS) technique [(12)] is one of the water 
suppression techniques popularly used. It is accomplished by water excitation with a 
frequency selective 90° pulse followed by a large dephasing gradient pulse.  A single CHESS 
pulse can achieve a suppression factor on the order of 100.  Usually three CHESS pulses are 
used to achieve a suppression factor of 1,000 to 10,000. 
Another problem is signal to noise ratio (SNR) of spectra due to relatively low 
concentration of metabolites (<= a few tenth of mM) compared to large water signal. Two 
methods are usually employed in order to improve SNR in MRS measurement. One way to 
achieve adequate SNR is signal averaging, which increases SNR by a factor of N (where N 
is the number of measurements). Increasing voxel size is another way to improve SNR. 
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Therefore, spatial resolution can be compromised in spatially localized MRS technique to 
improve the intrinsic low SNR in vivo. 
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Chapter 4 
 
Comparison of 2D* JPRESS & 2D* L-COSY on Detecting 
Polyamines and Citrate Metabolites for Prostate Studies 
 
 
4.1  INTRODUCTION 
 
High-resolution MR images are widely used to provide morphological information for 
initial diagnosis of prostate cancer after standard diagnosis methods. However, MRI alone 
suffers from poor specificity in detecting cancer in the prostate [(2)]. In order to differentiate 
malignant prostate cancer from benign cases such as BPH and prostatitis, which are very 
common in older men, proton MR spectroscopy (MRS) has been one of the widely used tools 
to improve clinical diagnosis non-invasively. However, the overlap of polyamine spermine 
with creatine and choline compounds causes inaccurate quantification of (choline + 
creatine)/citrate ratio that has been used as a biomarker. In addition, an increased intensity of 
the choline peak in spectra of tumor tissue may be obscured by a decreased neighboring 
spermine signal. Furthermore, the small metabolic changes in many cases such as early-stage 
cancer or infiltrative cancer, which have small tumors surrounded by healthy tissue, create 
difficulties in obtaining a clear-cut diagnosis due to significant partial volume effect. 
Therefore, more sensitive metabolic or physiologic markers that can help to discriminate 
prostate cancer at earlier stages of progression are needed. Polyamine spermine (Spm) itself 
has been identified as an additional potential metabolic marker in ex vivo NMR studies for 
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prostate cancer [(3, 4)].  In vitro and in vivo studies [(5)(6, 7)] showed quite high polyamine 
levels in normal prostatic tissue but considerably lower levels in prostate cancer.  
The main goal of in vivo proton MRS is the quantification of individual metabolite 
concentrations to monitor the corresponding changes due to pathological disease. However, it 
is difficult to determine some metabolite concentrations because of the generally complex 
and overcrowded spectra in 1D* proton MR spectroscopy. Peak assignment and metabolite 
quantification are difficult to employ due to the overlap of spectra in 1D* proton MRS. A 
large number of metabolites contribute to the in vivo proton spectra. For example, up to 35 
cerebral metabolites that can be detected by 
1
H MRS were recently reported by Govindaraju 
et al. [(8)]. Most of the resonances are limited to a narrow chemical shift range of 5 ppm in 
1D* proton MR spectrum. Multi-quantum NMR techniques [(37,38)] suffer from low 
sensitivity owing to intrinsic decreased signal strength because only certain coherence 
transfer pathways are selected. The spectral editing technique [(35,36)] has been gaining 
popularity due to its ability to differentiate certain metabolites from overlapping spectra or 
background to considerably increase its sensitivity. It has been used as a potential solution to 
solve the overlapping peaks. However, the main weakness of spectral editing is that it is only 
suitable for detecting one compound at a time, which severely weakens the unique ability of 
MRS techniques to encode the evolution of several metabolites simultaneously.  
Expanding 1D* MRS to a second dimension has been shown to be useful for resolving 
overcrowded spectra. It resolves the spectral overlap usually observed in 1D* spectrum and 
hence facilitates assignment of metabolite peaks and improves metabolite quantification. The 
second indirect dimension of 2D* MRS is encoded by varying the lengths of evolution 
periods, which can provide more metabolite information through off-diagonal cross peaks. 
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Since acquisition time is unlimited, these techniques are widely applied to the in vitro NMR 
field, providing a wealth of information such as correlations of coupled spins and 
connectivities [(9)]. On the other hand, for an in vivo study, due to constraints such as long 
acquisition time and high requirements on hardware, the application of two-dimensional 
spectroscopy in vivo is unpopular.  
Two-dimensional J-resolved spectroscopy is one of a few 2D* MRS sequences suitable 
for in vivo applications. For the 2D* L-JPRESS sequence, the volume localization is 
accomplished by Point-REsolved SpectroScopy (PRESS). It encodes the J coupling of spins 
in the second indirect dimension, thus the specificity of J-coupled metabolites detection is 
largely improved and the spectral overlap of resonances of 1D* proton MRS is resolved. 2D* 
L-COSY sequence, which utilizes the CABINET [(10)] scheme to employ volume 
localization, provides better spectral resolution although more acquisition time is needed. 
Thus, the attribution of 2D* COSY spectra is no longer solely based on chemical shifts of the 
resonance peaks, but also takes into account the 2D* fingerprint of each metabolite [(10, 11)]. 
The applications of 2D* L-COSY in human brain, breast, muscle, and spinal cord, have been 
investigated recently by several research groups.  
2D* J-resolved spectroscopy implemented at relatively low field strength is a powerful 
tool for detecting metabolites in the case of strong overlap in the chemical shift dimension. 
The applications of localized 2D* L-JPRESS in human prostate cancer studies were reported 
by several researchers. It enables the spectral separation of creatine (Cr) and choline (Cho) 
from polyamine spermine (Spm). Marinette and Yue et al. [(12, 13)(14)] demonstrated that 
the metabolites clinically used in prostate cancer studies such as citrate, choline, creatine, and 
polyamine spermine can be identified and the 2D* multiplet patterns of citrate and spermine 
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in JPRESS spectra were detected with a reasonable resolution.  However, the limited spectral 
resolution along the second axis (F1) resulted in an overcrowded 2D* L-JPRESS spectrum.  
This complex spectrum is due to the strong coupling effects of citrate, which produce 
entangled spectra hard to interpret. Kim et al.[(15)] combined 3D MR CSI with the 2D* L-
JPRESS method to detect the prostate tumor region. Lange et. al [(16)] recently presented a 
2D* Strong-coupling Point-REsolved SpectroScopy sequence (S-PRESS) particularly for 
citrate detection in prostate spectroscopy. However, due to relatively long echo times, 2D* L-
SPRESS is not an ideal method for the detection of metabolites with very short T2 relaxation 
constants such as polyamine spermine and lactate. A localized 2D* L-COSY sequence had 
been implemented to explore the 2D* L-COSY spectrum of prostate phantom at 7T [{{2 Liu, 
H. 2007;}}], which could get a better dispersion of J-cross-peaks for both polyamine 
spermine and citrate. Lange et.al [40,41] demonstrated in their studies that ProFIT-based 
quantification of 2D* JPRESS and 2D* L-COSY data showed the superiority of 2D* MRS 
over conventional 1D* MRS. More than six metabolites including creatine, total choline, 
citrate, polyamine, myo-inositol, and scyllo-inositol were quantified successfully. 
       In this chapter, to prepare for future in vivo human prostate studies, we describe the 
implementation of single-voxel localized 2D* L-COSY and JPRESS sequences that are 
suitable for investigating the metabolites composition of a prostate phantom within clinically 
acceptable acquisition times. The primary objectives of the present study were to 1) evaluate 
the performance of the 2D* 
1
H-MRS sequences in vitro (ex vivo) by using prostate phantoms 
and 2) implement 2D* L-JPRESS and 2D* L-COSY sequences and compare the 
effectiveness of each sequence in resolving the prostate metabolites such as polyamine 
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spermine, citrate, choline, creatine.  3) To prove the linear relationship between cross-peak 
volume of 2D* MRS techniques and concentration of metabolites. 
  
4.2 MATERIALS AND METHODS 
      The 2D* L-COSY sequence was first implemented on 7T MR system preparing for 
animal study. Both 2D* L-COSY and 2D* L-JPRESS sequences were developed on 4T 
whole-body MR system preparing for in vivo human studies. 
 
4.2.1 Sequence Diagram of 2D* L-COSY and 2D* L-JPRESS 
 
The JPRESS sequence shown in Fig. 4.2 is based on traditional PRESS sequence adding 
an incremental period (∆t1/2) before and after the last 180° RF pulse and 90°-∆-180°-∆-t1/2-
180°-∆- t1/2 –t2 (acquisition period). The 2D* L-COSY sequence, as shown in Fig.4.1, used 
three RF pulses 90°-180°-90° for volume localization. The added middle 180° did not  
 
        Figure 4.1 2D* L-COSY Sequence diagram             
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transfer coherence but flipped the coherence to accomplish the three dimensional volume 
selection compared to traditional 90°- 90° COSY sequences. The last 90° RF pulse also 
accomplished the coherence transfer necessary for correlating the metabolite resonances in 
the second dimension. Traditional sinc 90°and 180°RF pulses were used for localization with 
durations of 2 ms. The CHESS sequence was applied before the volume localization for 
global water suppression. 
 
        
 Figure4.2. 2D* L-JPRESS Sequence diagram  
 
4.2.2 MRS Parameters 
 
The implemented 2D* L-COSY and 2D* L-JPRESS sequence diagrams in this study are 
shown in Fig 4.1 and Fig 4.2. The 2D* L-COSY sequence is the same as Thomas et. al [(10)]. 
An 8-step phase cycle for COSY and a 16-step phase cycling scheme was used for 2D* L-
JPRESS on all three pulses respectively. Each slice-selective RF pulse was phase cycled 
along with add/subtract of the receiver, which led to a total of eight phase cycles for all three 
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RF pulses of COSY sequence. 2D* L-COSY spectra were acquired using the following 
parameters: TR = 2 sec, minimal TE of 28ms, 64 and 256 t1 increments were used to sample 
the second frequency dimension (F1). The raw data were acquired using 1024 complex points 
and the spectral window along the first dimension was 2.5 kHz and 1.25 kHz along the 
second dimension.  
For 2D* L-JPRESS, the parameters were TR = 2 sec, minimal TE of 34ms, 64 t1 
increments with 200Hz spectral window. The voxel size was 15mm
3
 for both sequences. The 
duration of trapezoidal coherence crushing and selection B0 gradient was about 2ms. The 
acquisition time for 2D* L-COSY with 64 echoes was about 34mins with 16 averages. TR = 
1ms data were also acquired on 2D* L-COSY sequences. A SECSY-mode acquisition was 
utilized to collect echoes and then the raw data set was converted to a COSY-presentation 
map by applying a phase correction to each row of the 2D matrix.  
 Individual 2D* L-COSY and 2D* L-JPRESS spectra of citrate, polyamine, and lactate 
were also acquired.  The parameters of 2D* L-COSY and 2D* L-JPRESS sequences for 
testing the linear relationship of cross-peak volume and concentration of metabolites were the 
same as corresponding single-voxel sequences. 
 
4.2.3 Phantom Solutions 
 
A prostate phantom with five metabolites was used and their concentrations were as 
follows: 90 mM citrate, 20 mM spermine, 10 mM choline, 10mM Lactate and 12 mM 
creatine to mimic prostate tissue (pH =7.0, 20% D2O). The spectra of 2D* L-COSY and 2D* 
L-JPRESS of four metabolites was also measured using the individual phantom solution of 
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the following metabolites: Citrate 50 mM, spermine 50mM, choline 50mM, and lactate 
50mM.  
In order to measure the linear relationship between cross-peak volume and concentration 
of metabolites, three phantoms were prepared. The first phantom included 20mM spermine, 
10mM choline, 12mM creatine (pH=7.0, 20% D2O).  The second phantom includes 40mM 
spermine, 20mM choline, 24mM creatine (pH=7.0, 20% D2O). And the third phantom 
includes 60mM spermine, 30mM choline, 36mM creatine (pH=7.0, 20% D2O). 
 
4.2.4 Data Acquisition 
 
All experiments were performed using a whole-body 4T MR scanner equipped with a 
SMIS console (Surrey Medical Imaging System, Surrey, UK). An in-house built birdcage 
coil was used for both radiofrequency (RF) transmission and signal detection.  
The 2D* L-COSY and 2D* L-JPRESS sequences with the CHESS water suppression 
were developed under the SMIS system and both were performed after the acquisition of 
three orthogonal scout images.  
      For all spectroscopic studies, standard sinc-modulated RF pulses of 2ms duration with 5 
kHz spectral width were used for slice-selective excitation that can minimize the chemical 
shift-misregistration. 
 
4.2.5 MRS Post-processing 
 
 Spectral processing was performed offline using self-customized MATLAB 
(MathWorks INC., USA) programs together with a multi-dimensional NMR data analysis 
package (MatNMR [(19)], which is a free highly flexible toolbox for processing 1D* and 
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2D* NMR and EPR spectra developed by Jacco van Beek).  The raw data were apodized 
with a sine-bell apodization function with a 90 phase shift along F2 only and zero-filled to 
128 x 2048 (for 64echoes data) for 2D* COSY individual phantom spectra and 512x2048 
(for 256 echoes data) for prostate phantom and 128 x2048 for 2D* L-JPRESS spectra. Post-
processing also included phase correction; DC offset correction, and multiplication by 0.5 to 
remove t1 ridges noises and 2D* Fast Fourier Transform.  All 2D* spectra were presented as 
contour plots. The resulting spectrum was displayed in magnitude mode. 
  
4.3 RESULTS  
 
4.3.1 2D* JPRESS in vitro 
Figure 4.3c shows the 2D* L-JPRESS MR spectrum of five metabolites (choline, citrate, 
creatine, spermine, lactate at pH = 7.0) obtained from the prostate phantom using the 4T 
whole body MRI scanner. A voxel size of 15x15x15 mm
3
 was localized at the center of the 
phantom.  Citrate, which has two mythylene groups (CH2) and is a strongly coupled AB spin 
system [(20, 21)], produced eight J-resolved 2D* peaks as shown in Fig 4.7c. The 2D* J- 
resolved cross-peaks positioned at F1 = ±6.0 Hz, ±7.5Hz, and ±19.0 Hz were similar to an 
earlier study [(16)]. While in Fig 4.7a, there were sixteen COSY cross-peaks. Fig 4.7b shows 
simplified two cross-peaks of citrate, which was collected at the 7T MR system. 
The other metabolites, along F1 = 0 Hz, the same as in the conventional 1D* spectrum, 
showed several overlapping peaks in the resonance region between 3.0ppm– 4.0 ppm: 
polyamines spermine (multiplets at 1.8ppm, 2.1ppm and 3.1 ppm), creatine (at 3.04ppm, 3.94 
ppm), choline tri-methyl singlet (3.20 ppm), choline methylene multiplets (3.55ppm, 
4.05ppm ppm), lactate doublet-of-doublets (1.31ppm), and lactate quartet (4.1ppm). The 
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spermine multiplet at 3.1ppm was overlapping with the choline tri-methyl singlet at 3.20 ppm 
and the creatine singlet at 3.04ppm. The choline multiplet at 4.05ppm was overlapping with 
the lactate quartet at 4.1ppm and the creatine singlet at 3.94ppm. 
The J-resolved cross-peaks of polyamine spermine methylene protons were shown at 
peaks of F2 = 1.8ppm, 2.1 ppm and 3.1 ppm (Fig 4.5). Since the methylene protons of 
spermine have weak J-coupling (Chemical shift difference >> J), the triple doublet anti-
symmetrically distributed around F2 = 3.1 ppm (F1 =0 Hz and F1= ±6.2Hz, F1= ±9.2Hz, F1= 
±16.0Hz) was clearly observable. The J-resolved cross-peaks due to choline were not well 
observable at 4T. 
The J-resolved quartet due to methyl and methylene protons of lactate (Fig4.6b) were 
centered at F2 = 4.1 ppm. Its cross-peaks were also anti-symmetrically positioned at 1.35ppm 
Two anti-phased cross-peaks were separated by J = 6.93Hz in figure 4.6b.  
The J-resolved peaks of creatine were not observable in Fig. 4.3c. 
      
4.3.2 2D* COSY in vitro 
 
Figures 4.3a and b show the 2D* L-COSY MR spectra of five metabolites (choline, 
citrate, creatine, spermine, lactate at pH = 7.0) obtained from the prostate phantom using the 
4T whole body MRI scanner. Voxel size is 15x15x15 mm
3
.   
In the 2D* L-COSY MR spectra, the diagonal peaks along F1 = F2 resemble the 
conventional 1D* spectral resonances: polyamines spermine (multiplets at 1.8ppm, 2.1ppm 
and 3.1 ppm), creatine (at 3.04ppm, 3.94 ppm), choline tri-methyl singlet (3.20 ppm), choline 
methylene multiplets (3.55ppm, 4.05ppm ppm), lactate doublet-of-doublets (1.31ppm), and 
lactate quartet (4.1ppm). Along the diagonal axis, similar to conventional 1D* spectra, there 
were several overlapping peaks in the resonance region between 3.0ppm– 4.0 ppm. The 
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spermine multiplet at 3.1ppm was overlapping with the choline tri-methyl singlet at 3.20 ppm 
and the creatine singlet at 3.04ppm. The choline multiplet at 4.05ppm was overlapping with 
the lactate quartet at 4.1ppm and the creatine singlet at 3.94ppm. 
The two strongly coupled mythylene groups (CH2) of citrate produced 16 cross-peaks (4T) 
symmetrically distributed around F2 = 2.45-2.75 ppm [(9)], as shown in Fig4.7 a. However, 
at high field 7T (Fig4.7c), 2D L-COSY spectrum [(23)], only two cross peaks around 
(2.55pm/2.65ppm, 2.65ppm/2.55ppm) were visible.  
Spermine shows two well-separated cross-peaks at (3.1 ppm / 1.8 ppm), (1.8 ppm / 3.1 
ppm) and (3.1 ppm / 2.1 ppm), (2.1 ppm / 3.1 ppm) in fig 4.4.  
In Fig4.8a and Fig 4.8b, the choline tri-methyl singlet (3.20 ppm) and the choline 
methylene multiplets (3.55ppm, 4.05ppm ppm) could be identified on the diagonal axis F1 = 
F2.  The COSY cross-peaks due to choline were also identified at (3.55ppm/4.0ppm, 
4.05ppm/3.55ppm). 
In Fig4.6a, the COSY cross peaks due to methyl and methylene protons of lactate were 
well isolated at (1.31ppm/4.1ppm, 4.1ppm/1.3ppm).  
From Fig4.3a Fig 4.3b, we can see there was no big difference with the cross-peaks of 
citrate, spermine, and choline using TR=2s and TR=1s, although the SNR theoretically 
decreased 50%. So that means we can use TR=1s to save almost half of the acquisition time, 
which is very useful for clinical applications. 
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Fig4.3a 2D* COSY spectrum of Prostate Phantom (contained Choline, Citrate, Spermine Creatine metabolites). 
Acquisition parameters are TR=1sec, ∆t1=0.8ms, 256 echoes, average=16. 
 
 
Fig4.3b.  2D* COSY spectrum of Prostate Phantom (containing choline, citrate, spermine creatine, lactate 
metabolites). Acquisition parameters are TR=2sec, ∆t1=0.8ms, 256 echoes, average =16. From above Fig4.3a 
Fig 4.3b, we can see there is no big difference with the cross-peaks of citrate, spermine, and choline using 
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TR=2s and TR=1s, although SNR decreased half. So that means we can use TR=1s to save almost of half of 
acquisition time.  
 
 
Fig 4.3c, 2D* JPRESS spectrum of Prostate Phantom (contained Choline, Citrate, Spermine Creatine, lactate 
metabolites). Acquisition parameters are TR=2sec, ∆t1=5ms, 64 echoes, average=16.  
 
 
Fig 4.3d. 2D* L-COSY spectra of prostate phantom (5 metabolites) displayed in 3D mode 
Acquisition parameters are TR=2s, 256 echoes, ∆t1=0.8ms, avg=16 
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Figure 4.4 COSY spectra of spermine (TR=2s, 64echo, ∆t1=0.8ms)  
              
Fig 4.5 JPRESS spectra of Spermine (TR=2s, 64echo, ∆t1=5ms) 
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                             3D contour plot                                                          2D contour plot 
Figure4.6a COSY spectra of Lactate in 3D and 2D contour plot  (TR=2s, 64echoes, ∆t1=0.8ms) 
 
 
Figure4.6b JPRESS spectra of Lactate (TR=2s, 64echoes, ∆t1=5ms) 
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      Fig 4.7a COSY spectra—Citrate TR=2s, 256 echoes, ∆t1=0.8ms, 16 cross-peaks were displayed 
          
 Fig4.7b. COSY spectra of prostate phantom at 7T, only two square splitting cross-peaks of citrate were shown. 
TR=0.8s, 256 echoes, ∆t1=0.8ms, 2 cross-peaks of citrate were displayed around 2.5ppm. 
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Figure4.7c. JPRESS spectra of citrate  (TR=2s, ∆t1=5ms, 64echoes), 8 cross-peaks are displayed.  
 
 
 
Figure 4.8a COSY spectra of Choline (TR=2s, 64echo, ∆t1=0.8ms), 2D contour plot  
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Figure 4.8b COSY spectra of choline (TR=2s, 64echo, ∆t1=0.8ms), 3D contour plot 
 
Figure 4.8c JPRESS spectra of Choline (TR=2s, 64echo, ∆t1=5ms), 2D contour plot 
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Table 4.1 Comparison of 2D* L-COSY and 2D* JPRESS Spectra of Normal Prostate Phantom 
 
From Table 4.1, spermine and choline J resolved cross-peaks were not all shown up in 
JPRESS spectrum, while in COSY spectrum, Spermine and choline were well isolated. The 
possible reason for Spermine and choline J-resolved cross-peaks not shown in JPRESS 
spectrum is that spermine is short T2 metabolite, while Choline concentration was low in 
normal prostate phantom.  
Table 4.2a Comparison of Spectral width (FWHM) of J-resolved cross-peaks in 2D JPRESS spectrum and cross 
peaks in 2D* COSY spectrum. Table 4.2b is the ratio of  Distance of two peaks divided by  the average of 
FWHM of two peaks.  (ratio = Distance /((FWHM1+FWHM2)/2) 
              
Table 4.2a      Table 4.2b 
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4.3.3 The linear relationship between cross-peak volume and  
concentration of Metabolites 
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Fig 4.9c     Fig4.9d 
Fig 4.10a     
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Fig 4.10b  
Choline/Creatine in COSY
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Fig 4.10c  
Spermine/Creatine in JPRESS
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Fig 4.10d 
Choline/Creatine in JPRESS
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More dispersed and relatively clean background                      Embedded in the background 
noise. 
     
 
    Fig 4.11. The better dispersion of choline cross-peak in 2D* L-COSY spectrum compared to 2D* L-JPRESS 
spectrum. A) 2D*L-COSY spectrum. B) 2D* L-JPRESS spectrum. 
 
From table4.2a and table 4.2b, we can see that metabolite cross-peaks in 2D* L-COSY 
spectrum have better spectral dispersion than J-resolved cross-peaks in 2D* L-JPRESS 
spectrum. The linear relationship between the integrated cross-peak volume and metabolite 
concentration in 2D* MRS was shown in Figs 4.9a~d. The linear relationship of integrated 
cross-peak volume over creatine peak height were also shown in Figs 4.10a~d.  In fig 4.11, 
the choline cross-peak in 2D* L-COSY spectrum showed better dispersion compared to 
choline J-resolved cross-peaks in 2D* L-JPRESS spectrum.  We can see that in 2D* JPRESS 
spectrum (fig 4.11), choline cross-peaks close to background noise, while in 2D* L-COSY, 
the cross-peaks of choline were well dispersed. 
4.4 DISCUSSION  
 
Two-dimensional J-spectroscopy provides the possibility of a complete separation of the 
effects of chemical shifts and homonuclear scalar couplings. This separation of shifts and 
couplings is an attractive approach since it enables the chemical shifts to be presented in a 
Choline JPRESS cross -peaks Choline COSY cross -peak 
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simple way, and also allows the separate study of each multiplet. For small molecules such as 
lactate and polyamine, the J-spectrum may allow the clear visualization of multiplets, which 
are overlapping in the conventional 1D* spectrum. 
 
4.4.1 Strong Coupling Effects of Citrate 
 
Previous 
1
H 3D (spatial dimension) MRSI and 2D* J-resolved or 2D* JPRESS studies of 
prostate diseases had proven their abilities to detect prostate cancer due to the corresponding 
changes in citrate [(1, 24, 25)] and choline metabolism that occur in the presence of cancer. 
In normal prostate, the citrate level is relatively high due to its abundant secretion by prostate 
epithelial cells and its oxidation is inhibited by the existence of high concentrations of zinc. 
However in the cancerous tissue, the citrate level is significantly diminished along with the 
considerable reduction of the zinc level. Citrate J-modulation can indirectly provide the early 
changes of prostate pathogenesis since zinc is not detectable by NMR 
1
H MRS. However, the 
strong coupling of citrate not only causes the citrate resonances to be dependent on the 
timing of sequence and magnetic field strength, but also creates very complicated J-
modulation peaks. In 1D* PRESS spectra of prostate, if echo-time is not correctly selected, 
the J-modulation of citrate resonance will sometimes obscure the measurement of citrate 
metabolites due to different shapes of the resonance peaks.  The optimization of echo time 
and MRS sequence design for detecting citrate were investigated by several research groups 
[(26, 27)]. 
 The citrate resonance signal arises from its two mythylene groups (CH2), which is a 
strongly coupled AB spin system at currently clinically used magnetic field strength (B0  <= 
7T).  In the 1D* PRESS spectra, the citrate resonances display as four lines centered at 
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2.6ppm (see fig4.12). The field independent coupling constant J is 16.1Hz. The chemical 
shift difference between the A and B spins (i.e. C and H, δ = 0.149ppm[(28)]) is linearly 
dependent on the magnetic field strength, which make the distance of two inner lines also 
dependent on field strength. The Hamiltonian for an AB spin system can be written as 
)(2)( zzyyxxZAZA BABABAJBAH +++Ω+Ω= π      (4.1) 
where Ax,y,z and Bx,y,z are the angular momentum operators in Cartesian coordinates, ΩA 
and ΩB are the chemical shifts of spin A and B, and J is the coupling constant of the two 
coupled spins A and B. The contribution from yyxx BABA + is characteristic of strongly 
coupled spin systems and is usually neglected in weakly coupled spin systems.  
                
Fig4.12 1D* PRESS spectrum of citrate. From MRM56: 1220-1228(2006)   
        In the 2D* J- resolved spectrum, strong coupling leads to additional peaks in the 
spectrum resulting in the appearance of lines in the projection, which are not at the chemical 
shift position. Peaks arising from strong coupling are usually called ‘strong coupling 
artifacts’ since the presence of these extra peaks detracts greatly from the simplicity of the 
spectrum and makes it ambiguous for interpretation.  The same problem happens to constant- 
time NMR experiments, as well as to other experiments that contain a J-resolved pulse 
sequence element [(29)], which include 2D* L-COSY sequence.  Strong coupling artifacts 
originate from a mixing effect caused when a 180° pulse is applied to a strongly coupled spin 
system [(29)]. It cannot be suppressed by a phase cycling procedure or application of pulsed 
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field gradients, since the artifact signals arise from the same coherence transfer pathway 
selected as the required signals. Both 2D* L-JPRESS and 2D* L-COSY sequences have this 
180°pulse during evolution period. Therefore, we can see the strong coupling effects from 
both spectra.   
        In our 2D* L-JPRESS spectra, citrate presented a typical spectral pattern of eight peaks 
as shown in Fig4.7c, which is consistent with a former study [(12,16)]. The J-resolved cross-
peaks appear at f1= {±J/2, ±Λ/2±J/2, ±Λ/2 J/2}(J=15.0Hz, δ=17.43Hz, Λ=
22 J+δ = 
23.0Hz). The additional peaks come from the coherence transfer between the coupled spins 
[(9)].  
 Our 2D* L-COSY 4T spectral results show that the 2D* correlation pattern of a strong 
coupling AB spin system is displayed as 16 phase-twist peaks with different amplitudes 
(Figure 4.7a), which make the spectra more complicated. Strong coupling may be suppressed 
at high magnetic fields. The coupling strength factor 
δ
κ
J
=  will decrease due to the 
increasing chemical shift δ(Hz) with a higher magnetic field. Fig 4.7b shows a 2D* L-COSY 
prostate spectrum collected at 7T by us using the same 2D* L-COSY sequence [{{2 Liu, H. 
2007}}]. As shown, we can see that the citrate J-spectra only displayed as two cross-peaks, 
which was much simpler.  This simplified COSY cross-peak pattern was similar to another 
citrate non-localized in vitro COSY spectra (90°-90°) collected at 600MHz (14T) by us 
(Results not shown here).  
The first successful method for suppressing these unwanted signals was shown by 
Thrippleton et.al. [(29)]. Thomas Lange et. al.[ (16)] also showed a method to decrease these 
additional peaks from 8 peaks to 6 or 4 peaks by using a 2D* L-SPRESS sequence.  However, 
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for clinically used magnetic fields, B0<=7T, more efficient strategies need to be developed to 
further suppress the strong coupling artifacts to simplify the measurement of citrate peaks in 
2D* MRS spectra. 
 
4.4.2 The Weakly Coupled Spins Systems (Chemical shift difference >> J) 
 ---Spermine and Lactate 
 
Compared to strongly coupled citrate, weakly coupled spins should show less J cross-
peaks in 2D* L-JPRESS spectra. In 2D* L-COSY spectra, the cross-correlation peaks for a 
two weakly coupled proton system should have a square pattern, with a J splitting in both 
dimensions.  
In our result, the 2D* JPRESS spectrum of lactate shows a simple splitting of the lactate 
resonance. Two peaks were separated by J = 6.9Hz in figure 4.6b. These two peaks are anti-
phased, therefore, the digital resolution in t1 increment direction must be equal to or greater 
than the coupling constant J to prevent its disappearance [{{61 Lange, T. 2006}}]. In the 
2D* L-COSY spectrum (Fig 4.6a), lactate shows well-dispersed J splitting cross-peaks at 
(4.1ppm, 1.31ppm) and (1.31ppm and 4.1ppm).  
Due to the weak J-coupling of methylene protons, the triple doublet of spermine anti-
symmetrically distributed around F2 = 3.1 ppm (F1 =0 Hz,  6.2 Hz, and -9.2Hz) which were 
clearly observable as six J-resolved cross-peaks (fig4.5). Our result is similar to the non-
localized J-resolved cross-peak pattern of spermine, which was collected ex vivo at 600MHz 
(14T) by Marianette [{{79 van der Graaf,M. 1996}}]. In our 2D* L-COSY spectrum (fig4.4), 
spermine shows two well-separated cross-peaks at (3.1 ppm / 1.8 ppm), (1.8 ppm / 3.1 ppm) 
and (3.1 ppm / 2.1 ppm), and (2.1 ppm / 3.1 ppm). In the 2D JPRESS spectra of prostate 
phantom (Fig 4.3c), the spectrum region between 3.0ppm~3.2ppm was still crowded with 
 78 
choline, creatine and spermine peaks because of the limited spectral dispersion. Spermine 
multiplets were not displayed at 2.1ppm and 1.8ppm. 
Comparing the 2D* L-JPRESS spectra to 2D* L-COSY spectra of both lactate and 
spermine, we can see that 2D* L-COSY spectra of both metabolites show increased spectral 
dispersion for weakly coupled spin system. 
      Furthermore,
 
for weakly coupled resonances, there is an additional signal
 
cancellation due 
to anomalous J-modulation, which would cause signal loss. Signal loss of lactate caused by 
the combined effects of chemical shift, voxel displacement and J coupling was thoroughly 
discussed by Lange T. [(30)].  
 
4.4.3 Choline and Creatine    
 
Several J-resolved cross-peaks due to choline were observable along F2= 3.55ppm and 
4.05ppm with relatively poor sensitivity due to limited spectral resolution at 4T and SNR. In 
a previous study [(22)], non-localized 2D* J-resolved spectra that were collected from 
prostatic biopsy material and a phantom at 600MHz (14T) showed clear J-resolved peaks at 
3.55ppm, and 4.05ppm. 
While the COSY cross-peaks of choline were well isolated at (3.55pm/4.05ppm, 
4.05ppm/3.55ppm) (Fig 4.8a and b), the J-resolved cross-peaks and COSY cross-peaks of 
creatine were not observable in Fig. 4.3a,b and c. 
 
4.4.4 Potential Use of Well-Resolved Cross-Peak in 2D* L-COSY Spectrum 
 
2D* MRS techniques provide not only an increase in spectral resolution, but also 
additional information on specific metabolites. The promising results of in vivo 2D* L-
COSY studies [(17)] showed that it can be used to monitor cross-peaks from metabolites 
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such as N-AA, the glutamate/glutamine lactate, GABA, which are widely involved in 
pathological processes and recovery states of the brain. 
The well-resolved cross-peaks of metabolites such as polyamine and lactate contain 
information on the concentration of these compounds. Therefore the concentration time 
course of a specific compound can be monitored by following the time course of the volume 
of its cross peaks.  
In the future, this unique characteristic can be applied to longitudinally monitor the 
metabolic change of prostate cancer biomarker-polyamines in an animal model being treated 
with chemo-preventive agents such as DFMO. Treated and untreated (control) groups of 
animals can be compared. The outcome of this study may provide a better understanding of 
the in vivo action of DFMO longitudinally towards prevention of prostate cancer. 
 
4.4.5 Parameters Selections In This Study 
 
      One of the major problems encountered in in vivo 2D* spectroscopy is the sensitivity 
issue. Usually, in comparison to the SNR of a 1D* experiment, the SNR of a 2D* MRS 
experiment drops more than half [(31)]. The decrease in SNR can be balanced by optimizing 
SNR in the 2D* experiment, which will dramatically improve its ability to track metabolism 
in vivo.  
The fundamental sensitivity is basically determined by the amount of magnetization 
transferred through the J interaction. Optimization of boundary values of t1 and t2 can greatly 
affect the sensitivity of the results [(32)]. The signal decay in t1 is determined by the T2 decay 
of spin systems. The acquisition time in the t1 domain should start at 
min
1t =1/J ms while 
should be on the order of or greater than = 2/J ms to optimize the transfer. The line 
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width of the peak implies the T2* of the metabolite, which determines the 
max
2t  and should be 
chosen to collect the whole echo for each t1 value. Ziegler et.al [(33)] suggested that if 
considering both experiment time and frequency resolution in t1 dimension, the 
acqt1 = 
min
1t −
max
1t = 50ms is appropriate if the digital resolution of 20Hz in f1 is chosen. For the 
selection of repetition time (TR), a reproducible initial spin state prior to each COSY pulse 
sequence and magnetization equilibrium along the z-axis should be achieved, thus the delay 
between COSY pulse sequences should be on the order of 3T1 [(32)].  
 
4.4.6 SNR 
 
The SNR of a 2D* L-COSY experiment can be further improved and optimized using a 
matched weighting function [(33)] that is proportional to the signal envelope, which can be 
implemented at the data acquisition stage or during the post-processing period. But in the in 
vivo case, the homogeneity of B0 is usually poor; therefore the Coherence Transfer signal 
would not be a function of both t1 and t2. Thus independent weighting functions can no 
longer be used. The SECSY acquisition mode is suggested to solve this problem because its 
acquisition in t2 is always started at the top of the Coherence Transfer echo. However, phase 
shift due to delay of acquisition window needs to be corrected after data acquisition. Ziegler 
et.al [(33)] recommended that if in a COSY experiment, using a SESCY mode acquisition, 
time delayed in acquiring the whole echo consists of delaying the time origin by ∆t2  = t1 - 
acqt2 /2. This would result in a phase shift of the spectra S(t1, ω2), Φ (t1) = ω2 [t1- 
acqt2 /2]. This 
phase shift can be corrected by applying to each row of the matrix S(t1, ω2) the phase 
correction: Φ (t1) =  ω2t1.  
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In our study, SESCY mode acquisition was used and the corresponding phase correction 
was applied. 
 
4.4.7 T2 decay  
 
The intensity of the cross peak is determined by the T2 value of the protons and depends 
on the coupling patterns. Short T2 relaxation times of the metabolite protons display a 
significant signal loss at long echo times. For 2D* L-JPRESS, owing to the increased t1 
increments, severe loss of metabolite signals occurs due to T2 decay during t1 delays. Because 
of longer echo time TE, 2D* J-resolved spectroscopy (including 2D* L-JPRESS and 2D* L-
SPRESS) are techniques well characterized to detect long T2 metabolites. The line-widths of 
resonance peaks of both 2D* L-JPRESS and 2D* L-SPRESS only depend on T2 decay 
instead of field inhomogeneities. In contrast, the line-widths of resonance peaks of 2D* L-
COSY depends on T2 decay and field inhomogeneities, which is not as insensitive to motion 
artifacts as 2D* J-resolved technique. 
 
4.4.8 t1 Ridge Noise 
 
     t1 ridge noise is a very annoying artifact caused by the instabilities of instruments and  the 
residue of unsaturated fat and water suppression. Random phase shifts of the spectra S(t1, ω2) 
contribute to the formation of noise ridges in ω1, which may overlap low-intensity cross 
peaks. It can be removed by symmetrization [(9)] or drift correction. 
 
4.4.9 The Linear Relationship Between Cross-peak Volume and  
 Concentration of Metabolites 
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Our results showed that the integrated cross-peak volumes in 2D* L-COSY and 2D* L-
JPRESS spectra were proportional to the concentration of metabolites, which was consistent 
with a former study [39]. Therefore, the cross-peak volumes in 2D* MRS can be used to 
calculate the metabolite ratio as in 1D* MRS for further clinical applications. 
 
4.4.10 Summary of Three 2D* Sequences 
 
2D* L-JPRESS (90°-180°-180°) enables the separation of chemical shift and coupling 
information for J-coupled metabolites. It helps distinguish J-coupled metabolites from 
uncoupled resonances. All its cross-peaks have the same “phase-twisted” line shape, with 
equal absorptive and dispersive contributions [(17)].  In the extended indirect dimension F1, 
better spectral resolution can be obtained for these coupled spins. The line-widths of 
resonance peaks only depend on T2 decay instead of field inhomogeneities.  The use of 180° 
refocusing RF pulses during increments delay makes this sequence insensitive to B0 field 
inhomogeneities, therefore suitable for use in in vivo studies.  
 However, the major drawback of 2D* L-JPRESS is that the strong coupling effects of 
citrate make the JPRESS spectra too complex to interpret.  A modification of 2D JPRESS---
2D* L-Strong coupling Point-Resolved SpectroscopY (L-SPRESS) is a special form of 2D* 
JPRESS sequence keeping the PRESS localization scheme. It varies the lengths of the first 
and second TEs but keep the total echo time (TE) constant to obtain a series of PRESS 
spectra. It was designed specifically to detect strong coupling AB spin systems such as citrate, 
which makes accurate detection of citrate possible. Like 2D* L-JPRESS, it keeps the 100% 
signal sensitivity. However, in the 2D* L-SPRESS spectrum, only strong coupling spins such 
as citrate are spread out in the second extended dimension. As a result, only one metabolite 
can be detected per measurement, which makes the MR spectra measurement inefficient if 
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multiple metabolites need to be monitored. Another limitation is that it needs longer TEs than 
common coherence filtering techniques. Hence, it is not a method of choice for metabolites 
with very short T2 relaxation.  
From this experiment we can see the appearance of additional cross-peaks of strong 
coupling systems for both sequences. Strong coupling artifacts of the type described above 
for J-spectra will appear in any spectrum for which the pulse sequence contains a 180° pulse 
within the evolution time [(29)]. Most of these strong coupling signals can be removed by 
increasing B0. i.e. at higher fields the effect of strong coupling is limite, and 2D* MRS 
spectroscopy can be used to efficiently investigate the metabolic processes in small animals 
[{{21 M´eric P. 2004}}]. 
Compared with the 2D* L-COSY, a major advantage of 2D* L-JPRESS is the reduced 
spectral width along the second spectral dimension and shorter 2D* spectral acquisition. In 
contrast, increased spectral width along the new spectral dimension in L-COSY results in an 
improved spectral dispersion enabling the detection of more metabolites at low 
concentrations that have not been resolved using the conventional one-dimensional (1D*) 
MRS techniques.  
 Compared with 2D* L-JPRESS, increased spectral width (smaller t1 incremental delays) 
along the new spectral dimension in 2D* L-COSY, which explores the correlation of the 
coupled spins to better separate them from other nuclei with a similar chemical shift, resulted 
in an improved spectral dispersion and better separation of various 2D* cross-peaks. COSY 
spectrum shows better J-cross peak dispersion than 2D* L-JPRESS and 2D* L-SPRESS 
spectra. But it requires a larger spectral window to be sampled during the evolution period. 
Polyamine, choline and creatine peaks are very well resolved in the 2D* L-COSY spectrum. 
 84 
Another advantage of the 2D* L-COSY technique is that the well-resolved cross-peaks 
can be utilized for longitudinal monitoring of specific metabolites in in vivo studies. 
However 2D* L-COSY (with CABINET selection) MR spectra can only retain 50% of 
the sensitivity from a localized volume of interest (VOI).  
 
4.5 CONCLUSIONS 
 
In summary, spatially localized 2D* L-JPRESS and L-COSY spectroscopic sequences 
have been successfully implemented on a 4T MRI/MRS scanner. Due to the limited spectral 
dispersion, the cross peaks of 2D* J-resolved spectra were still crowded and complicated. 
The additional J-cross peaks of strong coupling spins creates the difficulty of unequivocal 
identification and quantification of prostate metabolites for 2D* L-JPRESS spectra.  
J-coupled connectivity has been demonstrated in several prostatic metabolites in 2D* L-
COSY spectra. Compared with the previously reported 2D* JPRESS spectra using a 1.5 T 
MRI scanner [(12, 13)], improved spectral dispersion and better dispersion of J-cross-peaks 
facilitates the recording of polyamine and lactate. Citrate cross-peaks are still too 
complicated to be accurately identified using 2D* L-COSY. The combination of 2D* L-
COSY with 3D MRSI may improve detection of prostate cancer, or for evaluation of 
chemoprevention efficacy using polyamine and lactate as the biomarkers. 
 
 
 
 
4.6 FUTURE WORK 
 
2D* L-SPRESS is well suited for accurate detection of strong coupling citrate levels, 
while 2D* L-COSY is characterized for accurate detection of polyamines and lactate levels, 
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which have short T2 relaxation times and well-resolved COSY cross-peaks. Combination of 
2D* L-COSY with 2D* L-SPRESS may improve diagnosis of prostate cancer. 
Several drawbacks of 2D* MRS techniques prevent their use in in vivo applications. 
Collection of the whole 2D* data set is time-consuming in time-limited clinical applications. 
Therefore, more efficient 2D* MRS techniques need to be developed to shorten the 
acquisition time. In the future, rapid encoding of k-space (spiral or echo-planar) [(34)] could 
be combined with the 2D* L- COSY or J-resolved sequences to decrease the minimum 
experiment time (although at the price of a decrease in SNR or voxel bleeding).  
Future work, which can suppress the strong coupling artifacts of citrate more successfully, 
should also be developed to facilitate the quantification of citrate resonances in prostate 
cancer studies. 
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Chapter 5 
 
Multi-Voxel Excitation, Hadamard Encoding and Hadamard RF 
Pulse Design 
 
 
One of the attractive characteristics of Magnetic Resonance Spectroscopy (MRS) is that 
MRS can obtain localized metabolic changes of tissue to supplement morphologic 
information obtained by MRI or other imaging modalities. A spatially localized MRS 
technique is required to obtain the in vivo spectroscopic information.   
In vivo study strongly depends on the accurate localization of detection methods. Spatial 
localization is the accurate assignment of a detected signal to a specific volume of tissue 
within an anatomical region of the body. Currently, single-voxel MRS and multi-voxel MRS 
have been widely used.  There are two ways to employ multi-voxel localization including 
Fourier based Chemical Shifting Imaging (CSI)[(1, 2)] (or Magnetic Resonance 
Spectroscopic Imaging (MRSI)) and Hadamard based multi-voxel MR Spectroscopy [(3-10)]  
In this chapter, a brief introduction of volume localization techniques will be given. The 
Fourier based CSI and Hadamard MRS technique [(11)] will be presented and the 
development and implementation of Hadamard RF pulse design will be introduced in detail.  
 
5.1 Volume Localization Techniques for MR Spectroscopy  
 
A wide variety of accurate spatial localization techniques [(12)] have been developed for 
MR spectroscopy. Slices or volumes of interest can be selected by the application of 
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frequency-selective RF pulses in the presence of a B0 magnetic field gradient. Usually, three 
slice-selective pulses (PRESS sequence: 90° – 180° – 180°, STEAM sequence: 90° – 90° – 
90°) along three orthogonal axes, which define three orthogonal slices, create localization of 
a cubic voxel formed by the intersection of the three slices. Each volume selection technique 
combined with different coherence selection has its own advantages and disadvantages based 
on signal strength obtained, efficiency, artifacts and echo time etc. In this thesis, the 
Coherence trAnsfer Based spIN-Echo spectroscopy (CABINET)[(13)] (90° – 180° – 90°) 
volume selection technique will be used and details will be provided in the later section. Fig 
5.1 shows a single-voxel as defined by the intersection of three orthogonal planes. 
 
        Fig 5.1 A single-voxel (interior box) is defined by the intersection of three orthogonal plane. 
 
5.2 Single-voxel and Multi-voxel MR Spectroscopy 
 
MR Spectroscopy techniques can be classified into two general categories: single-voxel 
spectroscopy and multi-voxel spectroscopy.  
 
5.2.1 Single-voxel Spectroscopic Techniques 
 
There are numerous single volume localization techniques, the most popular include 
STEAM (STimulated Echo Acquisition Mode) and  PRESS (Point RESolved Spectroscopy).  
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STEAM contains three successively applied selective 90° RF pulses with the selection 
gradients in three orthogonal directions to obtain a localized volume. At first, the proton 
spins within the selected slice will be tipped down onto the xy-plane (transverse plane) from 
the longitudinal z direction by the first 90° RF pulse. After that, due to T2 relaxation and 
magnetic field inhomogeneity, the spins will dephase. The second 90° RF pulse application 
at time TE/2 will flip the spins (magnetization) back to longitudinal directions where it 
remains for a time delay TM. The echo time is independent of TM. The last 90° RF pulse 
will flip the magnetization to the xy plane again. Finally, a stimulated echo will be formed at 
TE/2 after the third 90° RF pulse is applied. 
PRESS includes the first 90° RF pulse and two subsequent selective 180° RF pulses in 
three dimensions to localize a selected volume. The first 90° RF pulse with the selection 
gradient generates the transverse magnetization in the selected slice, then the spins dephase 
due to the field inhomogeneity and T2 relaxation. But the selective 180° RF pulse together 
with gradient selects an intersecting slab, the dephased spins inside this slab are rephased by 
the 180° RF pulse at echo TE/2. The third 180° RF pulse with gradient further defines the 
volume being selected and refocuses the dephased spins again in the transverse plane at echo 
time TE. 
 
5.2.2 Multi-voxel MR Spectroscopic Imaging (MRSI) Techniques 
 
 Due to tissue heterogeneity and the necessity of investigating metabolite changes 
between abnormal and normal tissues, a multi-voxel MRS can provide extensive delineation 
of volume of interest (VOI).  The most popular techniques are the Fourier based CSI 
(Chemical Shift Imaging) and the Hadamard MRS technique.    
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5.2.2.1 Chemical Shift Imaging (CSI) Technique. 
 
In 1982, AA. Maudsley [(14)] et. al first proposed the idea of encoding spatial and 
spectroscopic information simultaneously in the MR signal. N-dimensional spectroscopic 
imaging refers to N spatially encoded dimensions and an additional spectral dimension (1D*) 
containing the spectroscopic information. 
Fourier-based Chemical Shift Imaging (CSI), which is also referred to as Magnetic 
Resonance Spectroscopic Imaging (MRSI), is a method for collecting spectroscopic data 
from multiple adjacent voxels (or slices) covering a large VOI in a single measurement. 
Spatial localization is accomplished by phase encoding in one (1D CSI), two (2D CSI) or 
three dimensions (3D CSI). The spatial encoding in N dimensions can be achieved by phase 
encoding in N orthogonal directions within the selected region of interests. A CSI sequence 
is similar to an imaging sequence but without applying readout gradients during data 
collection.  The N spatially encoded information can be decoded by Fourier Transformation 
in N directions from the acquired Free Induction Decay (FID) data set.  
Both spectral maps and metabolites images generated by the multi-dimensional Fourier 
Transform yield spatially localized metabolic maps, which can be color coded and overlaid 
on corresponding MR images to provide a visual metabolic map. 
 
5.2.2.2 Hadamard Multi-voxel MR Spectroscopy  
 
Hadamard multi-voxel MRS is based on using multi-radiofrequency selective RF pulses  
to obtain the spatial encoding of the spectral information from multiple voxels. The multi-
frequency excitation pulse simplifies the pulse sequence diagram and can be easily 
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implemented, while the successive excitation method has the advantage of variable volume 
sizes. In this thesis, the multi-radiofrequency selective RF pulses method is used to 
accomplish Hadamard encoding.  
 
5.2.2.3 Hadamard Multi-voxel MRS vs CSI Multi-voxel MRS 
 
In Hadamard encoded experiments, multi-radiofrequency selective RF pulses are used for 
spatial encoding, while in 
1
H MRSI, the phase-encoding gradients are used instead. The 
multi-voxel Hadamard spectroscopic technique has the benefits of either reducing the voxel 
size or reducing the data acquisition time or a combination of both owing to the improvement 
of the SNR when compared to chemical shift imaging (CSI). In general, a N  fold gain in 
sensitivity is obtained for N encoded voxels.  CSI allows voxel shift flexibility to align with 
abnormality, but all the voxels have to be contiguous. Another disadvantage of CSI is long 
data acquisition time. In addition to N  improvement of SNR, Hadamard MRS also has the 
advantage of avoiding voxel bleeding, details will be given in chapter 6. Both Hadamard 
MRS and Fourier based CSI suffer from chemical shift mis-registration artifacts. Fourier 
encoding CSI is usually integrated with Hadamard encoding to complement each other’s 
strengths and weakness. 
In the following section, slice selection of multi-voxel excitation techniques will be 
described. How the multi-voxel excitation RF pulses excite multiple slices and multiple 
voxels for polar RF systems will be investigated. And the computer simulation of multiple 
slices of the multi-frequency excitation RF will be demonstrated. 
 
5.3 Slice Excitation 
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5.3.1 Bloch Equation 
 
The static magnetization of the multi-frequency excitation RF pulse design is a solution 
of the famous Bloch equation. 
 The magnetization vector model was developed by F. Bloch, who considered the net 
macro magnetization of an object. The vector was put in a static magnetic field 0B

, as the net 
resultant of all magnetization vectors M

(t). In the laboratory rotating reference frame, the 
distribution of magnetization of in a magnetic field described by Bloch’s equations can be 
expressed as follows: 
 
                                    Fig 5.2 Creation of transverse magnetization by applying an RF pulse. 
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     )(1 tB

 is the applied RF field that rotates the Larmor frequency ω to transverse plane. 
   0B

 is the static magnetic field.   
   G

is the gradient field. 
    γ is the gyromagnetic ratio of nuclear spins. (Here: proton hydrogen 1H.) 
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   0M

 is the thermal equilibrium magnetization. 
   eqM

 is the longitudinal magnetization. 
    xˆ  yˆ  zˆ  are the unit vectors for the Cartesian coordinates x, y, and z 
    As fig 5.2 shows,  a radiofrequency pulse is needed to rotate the equilibrium magnetization 
eqM

along the Z direction into the x-y transverse plane as xyM

, which can be detected by the 
receiver coil. The flip angle θ, which is produced by )(1 tB

can be expressed as follows: 
ptB τγθ ⋅⋅= )(1

                           (5.2) 
where pτ  is the RF pulse duration. 
Spatial information about the distribution of the magnetization of nuclei (mainly proton 
1
H, others nuclei include 
13
C, 
31
P, 
23
Na in living body) can be encoded to create an MR image 
or spatially resolved MR spectroscopy by MR resonance frequency.  MR resonance 
frequency depends on the local magnetic field.  
 
5.3.2  Single Slice Excitation 
 
Fig 5.3 Basic principle of selective excitation 
 97 
Fig 5.3 shows the basic principle of selective excitation. When a linear gradient is applied 
along a certain direction (e.g. z axis), the amplitude of the static magnetic field will vary 
linearly along this gradient. By applying a narrow-band single-frequency RF pulse, only 
spins precessing at the resonance frequency in this frequency band within this slice will be 
excited, therefore only these spins will contribute to produce the MR signal.  
The slice thickness of the selected slice depends on the RF pulse bandwidth, RF length 
and the magnetic field gradient strength. The relationship is shown as follows: 
           
pzz
RF
G
N
G
BW
ThicknessSlice
τγγ
==_             (5.3) 
Where      BWRF is the RF bandwidth,   Gz is the gradient field strength 
            γ is the gyromagnetic ratio 
           τp is the RF pulse duration and  N is the zero-crossing point of the sinc function. 
Fig 5.4 shows the difference between spin distribution of the whole volume excitation 
and slice selective excitation. The slice-selective RF pulse excitation results in the transverse 
magnetization from a slice, while the whole volume excitation is usually down by hard an RF 
pulse, which results in the transverse magnetization from the whole volume. 
 
Fig 5.4 The spin distribution of the whole volume excitation and slice selective excitation. 
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Fig5.5 The RF pulse waveforms and the corresponding generated pulse spectra. 
 
The Fourier Transform (FT) of a cosine function is a delta function, while the FT of a 
sinc function is a rectangle. Thus, the FT of the multiplication of these two functions in the 
time domain will yield the convolution of each FT of the individual function in the frequency 
domain. Fig 5.5 showed the RF pulse waveforms and their spectra. The excited slice 
thickness is determined by 2ωs of the sinc function. 
 
5.3.2 Simultaneous Multi-voxel Excitation 
 
By combining the multi-frequency RF pulses with a volume localization pulse sequence 
such as PRESS, STEAM or CABINET etc., multiple voxels can be excited simultaneously. 
The number of voxels excited not only depends on the number of frequency bands in one 
multi-frequency RF pulse, but also the numbers of multi-frequency RF pulses applied as slice 
selections in N-dimensions. If a multi-frequency RF pulse with two excitation bands in 1D is 
applied, then two voxels will be selected. If a multi-frequency RF pulse with four excitation 
bands in 1D is applied, then four voxels will be selected. 
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5.4 Hadamard Encoding –Mathematical Basis 
 
A Hadamard matrix is a type of square matrix invented by Sylvester and Hadamard [ ?]. 
In a Hadamard matrix, placing any two columns or rows side by side gives half the adjacent 
cells the same sign and half the other sign.  
If an  nn×  square matrix ijnn hH =×  is a Hadamard matrix of order n, with all the entries 
being +1 or –1, then     
nIHH
T
nnnn =××                                        (5.4) 
where I is nn×   the  identity matrix.  
 
 
                                     
                            Fig 5.6    2x2 Hadamard image              Fig5.7  4x4 Hadamard image 
 
A Hadamard matrix has four important properties: 
1. The order of a Hadamard matrix is 2
n-1
, where n is an integer. 
2. The rows and columns of a Hadamard matrix can be permuted still remaining a   
    Hadamard matrix. 
3.  If any row or column is multiplied by –1, the Hadamard property is retained. 
4. The inverse of a Hadamard matrix 1)( −H is  
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      nn
T
nnnn H
n
H
n
H ××
−
× ==
11
)( 1                 (5.5)   
where 
T
nnH × is the transpose of Hadamard encoding matrix. 
The lowest order Hadamard encoding matrix is given by [H]2x2.  
[H]2x2 = 


+
+
1
1
  
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−
+
1
1
      [H]4x4 = 
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










+−−+
−−++
−+−+
++++
1111
1111
1111
1111
            (5.6) 
The element of xij of  m × m Hadamard matrix can be expressed as  
{ }∑−=
−
=
−−
1
0
)1()1(
)1(
n
k kk
ji
ijx           (5.7) 
Where n= m2log , and (i)k and (j)k are the kth bit in the binary representation of  i and j. 
 
5.5 Hadamard MR Spectroscopy Technique 
 
5.5.1 Hadamard MR Spectroscopy 
 
By applying the multi-frequency selective RF pulse with two-excitation bands in one 
slice selection direction, two slices or two localized volumes will be excited simultaneously.  
The phases of the two composite Hadamard RF pulses are showed in table 5.1. In order to 
use the Hadamard encoding scheme, two consecutive scans will be performed. One 
acquisition used a composite RF pulse, with two phases positively superposed denoted as 
‘++’. The second acquisition used a different composite RF pulse, with two phases reversely 
phased denoted as ‘+-’.  Therefore, the final phases in the two selected slices or (volumes), 
which result from the two consecutive acquisitions, synthesized differently. If Si is used to 
express the real FID signal from each sub-voxel, while using  is used to express the FID 
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signal acquired from above two subsequent acquisitions, the relationship between Si  and iS ′  
can be expressed by using the 2 ×2 Hadamard matrix as follows: 
       [S´]2x1 = 
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′
′
2
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S
S
= 


+
+
1
1
  


−
+
1
1






⋅
2
1
S
S
=[H] 2x2  · [S]2x1                   (5.8) 
where [H] 2x2  is the second order Hadamard matrix. Therefore, equation (5.8) can be solved 
by multiplying the inverse second order Hadamard matrix as follows: 
         [S]2x1 =([H] 2x2) 
-1
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
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2
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                                          (5.9) 
    For four voxel simultaneous excitation in one-dimension, four-frequency composite RF 
pulses should be applied.  The design of these four-frequency composite RF pulses is shown 
in section 5.6.2 and 5.6.3. 
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Four interleaved acquisitions (See table 5.2) need to be performed to finish the Hadamard 4
th
 
order encoding according to the Hadamard matrix.  Therefore, the phase within one slice or 
one localized volume is synthesized differently. The MR signal of each slice or localized 
volume can be derived mathematically according to equation (5.11). 
 
5.5.2 SNR of Hadamard MRS 
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Simultaneous excitation of multiple slices can be obtained by using the Hadamard 
encoding matrix in conjunction with selective RF excitation pulses. One of the advantages of 
using the Hadamard encoding matrix is the SNR gain of N , where N is the Hadamard 
matrix size. The derivation of N gain of the SNR of element S1 is described as follows: 
 
)...(
1
1211 nn SSSS
N
S ′+′++′+′= − ∑
=
′=
n
k
kS
N 1
1
             (5.12) 
Where S1 is the decoded signal for the first element and nS ′ is the nth encoding element. 
The signal to noise ratio is defined as follows. 
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Assuming  
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  SNRHadamard is the signal to noise ratio with the Hadamard encoding while SNRs is the 
signal to noise ratio without Hadamard encoding. 
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5.6 Simultaneous Multi-slice Excitation by Hadamard RF pulse 
 
5.6.1 Two-slice Hadamard RF Pulse Design 
The multi-frequency excitation RF pulse can be implemented in an SMIS system for the 
polar coordinate RF system. The FT of the cosine function is two Delta functions, which are 
aligned with the real axis in the frequency domain. While the FT of the sine function is two 
Delta functions with a reverse phase shift of 180°, which are aligned with the imaginary axis 
in the frequency domain. In order to shift the delta functions with opposite polarities to the 
real axis, a 90° phase shift should be introduced to the Sine modulated RF pulse spectra in 
the frequency domain.  
Table 5.1 The RF combinations of interleaved acquisition in one-dimensional Hadamard two-voxel 
imaging and spectroscopy study. 
 
       
Composite RF 
Combinations in 
one Directions 
# of Acquisition sequence X, Y or Z directions 
1 TR   + +  
2TR   +  -  
 
Therefore, with the application of a selection gradient, two slices with the same phases 
(++) will be obtained by using the cosine modulated RF waveform; while two slices with 
opposite phases (+ -) will be obtained by using the sine modulated RF waveform. In the polar 
coordinate system, the off-center single slice can be obtained by shifting the transmit 
frequency ω0 to ω0, with the non-modulated RF kernel. Hence, by shifting the transmit 
frequency to the offset frequency ω0   corresponding to the center of the two slices of interest, 
two slices can be excited simultaneously by using sine or cosine modulated RF waveforms 
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with the application of selection gradient. By Hadamard mathematical decoding, the signal 
from each slice will be extracted. 
Table 5.2  Final Phase of the FID signal obtained from each of the two excited voxels or slices 
  Final Phase for Each voxels or slices 
# of Acquisition sequence Sa Sb 
1 TR + + 
2 TR + - 
 
Fig 5.8 Phase map of selected volumes (slices) from two successively interleaved acquisition sequences 
according to table 5.2. The white volume has the positive (+) final phase while the shaded volume has the 
negative (-) final phase. 
 
Cosine modulated RF waveforms can be used to simultaneously excite two slices with 
the same polarities (+ +) for scan sequence #1. The modulated RF waveform kernel for both 
slices excitation can be designed as follows: 
a) )cos()(sin ttcARF s ωω ∆⋅⋅=++         (5.18) 
++⋅⋅= RFtRF )cos(211 '0ω  
)cos()(sin)cos(2 '0 ttcAt s ωωω ∆⋅⋅⋅⋅=  
= )(sin])cos()[cos( '0
'
0 tcttA sωωωωω ⋅∆++∆−⋅     (5.19) 
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stctA ωωω ⋅∆+⋅                     
Sine modulated RF waveforms can be used to simultaneously excite two slices with the 
reverse polarities (+ -) for scan sequence #2.  
b) )sin()(sin ttcARF s ωω ∆⋅⋅=−+        (5.20) 
−+⋅∆+⋅= RFtRF )cos(222 '0 φω  
)sin()(sin)
2
cos(2 '0 ttcAt s ωω
π
ω ∆⋅⋅⋅+⋅= = )sin()(sin)sin(2 '0 ttcAt s ωωω ∆⋅⋅⋅⋅  
= )(sin])cos()[cos( '0
'
0 tcttA sωωωωω ⋅∆+−∆−⋅     (5.21) 
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∆+∆
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Where '0ω  is the new center frequency (transmit) for the modulated RF waveforms to 
excite two off-center slices simultaneously. 
 is the original transmit center frequency for the slice excitation. 
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ω∆  is the difference of the two offset frequencies corresponding to two off-center slices. 
∆Φ is 90°  phase shift, which shifts the sine modulated RF waveform from the imaginary 
axis to the real axis. 
sω  is half to the RF bandwidth. 
1ω∆  and 2ω∆ are the frequency offsets of the two simultaneously excited slices.  
cω  is the new center of the frequency offsets of two excited slices. 
 
Fig 5.9 The signal polarity of the two excited volumes or slices after applied composite ‘++’ and ‘+-’ RF pulses. 
(a) shows the spectra of two adjacent selected slices(or volumes) with corresponding signal polarities. (b) shows 
the spectra two separately selected slices (or volumes) with corresponding signal polarities, ∆ω here is the RF 
pulse bandwidth.   
 
The Fourier Transforms of these RF waveforms turn out to be the convolution of a 
rectangular function tsω(Π ) and two delta functions 2,1),( 0 =∆+ iiωωδ , whose centers are 
10 ωω ∆+ and 20 ωω ∆+ . 
  
1#
1011 )()()(
Slice
stARFFT ωωωδ Π⊗∆+⋅=  +
  
2#
20 )()(
Slice
stA ωωωδ Π⊗∆+⋅       (5.23) 
       (5.24) 
 107 
Therefore, after add/subtract mathematical manipulations of the above two equations 
(5.23) and (5.24), cleanly decoded separate MR slice signals will be obtained (See fig5.15). 
 
5.6.2 Four-slices (in 1D) Hadamard RF Pulse Design 
 
  The extension to excite 4 or more slices/voxels in one dimension is very straightforward. 
Just replace the two-frequency excitation pulse with a four-frequency excitation pulse and 4 
slices or four localized volumes will be excited simultaneously. Table 5.3 shows the RF 
combinations of interleaved acquisition in a one-dimension Hadamard four-voxel imaging 
and spectroscopy study.  The notation ‘ + + + + ’ denotes the composite RF pulse is the 
superposition of four positively phased RFs, while the notation ‘ + + - - ’ denotes that the 
composite RF is the superposition of two positively and two oppositely phased RFs etc. 
Figure 5.11 shows the phase map of selected volumes (slices) from four successively 
interleaved acquisition sequences according to table 5.3, while table 5.4 shows the phases of 
signals obtained from each of the four excited voxels or slices for further decoding. And 
figure 5.11 shows the phase map of selected volumes (slices) from four interleaved 
acquisition sequences according table 5.3. 
Table 5.3 The RF combinations of interleaved acquisition in one-dimensional      
                             Hadamard four-voxel imaging and spectroscopy study. 
 
  
Composite RF 
Combinations in one 
Directions 
# of Acquisition sequence X, Y or Z directions 
1 TR   + + + + 
2 TR   +  - +  - 
3 TR   + +  -  - 
4 TR   +  -  - + 
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Table 5.4  Phase of the signal obtained from each of the four excited voxels or slices 
  
Final Phase for Each voxels or slices
# of Acquisition sequence Sa Sb Sc Sd 
1 TR + + + + 
2 TR + - + - 
3 TR + + - - 
4 TR + - - + 
 
Fig 5.10  Phase map of selected volumes (slices) from four successively interleaved acquisition sequences 
according table 5.4. The white volume has the positive (+) final phase while the shaded volume has the negative 
(-) final phase. 
 
Assuming '0ω  is the new center frequency (transmit) for the modulated RF waveforms to 
excite four off-center slices simultaneously. 
0ω  is the original transmit center frequency for the slice excitation. 
21ω∆ , 43ω∆ are the differences of the two offset frequencies corresponding to four off-
center slices. 
∆Φ is a 90°  phase shift, which shifts the sine modulated RF waveform  from the 
imaginary axis to the real axis. 
 is half to the RF bandwidth. 
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1ω∆ , 2ω∆ , 3ω∆ , 4ω∆  are the frequency offsets of the four simultaneously excited slices.  
      cω  is the new center of the frequency offsets of four excited slices. 
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Sine and Cosine modulated RF waveforms can be used to simultaneously excite 4 slices 
with different polarities according to 4
th
 order Hadamard matrix. The details are as follows. 
a).  ))cos()(cos()(sin 4321 tttcARF s ωωω ∆+∆⋅⋅=++++  
++++⋅⋅= RFtRF )cos(21111 '0ω  
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5.6.3 2D Four-volume Hadamard RF pulse design 
 
Similarly, in order to excite four slices or volumes in two dimension, two multi-
frequency RF pulses with the phase polarities described in table 5.5 can be applied in the X 
and Y directions. Four interleaved acquisitions are needed for a Hadamard four-voxel 
imaging and spectroscopy study.  Fig 5.10 shows the phase map of selected volumes (slices) 
from four interleaved acquisition sequences for two-dimensional selection. 
     Table 5.5 The RF combinations of interleaved acquisition in 2D      
                             Hadamard four-voxel imaging and spectroscopy experiment. 
 
  
Composite RF Combinations 
 in two Directions 
# of Acquisition 
sequence 
X Y 
1 TR +  + +   + 
2 TR +  - +   - 
3 TR +  + -   - 
4 TR +   - -   + 
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Fig 5.11 Phase map of selected volumes (slices) from four successively interleaved acquisition sequences (here 
shows two-dimensional selection. The white volume has the positive (+) final phase while the shaded volume 
has the negative (-) final phase. 
 
 
5.7 Simulation of Multi-Slice Excitation and Hadamard Decoding 
5.7.1 Computer Simulation of Two Slices Excitation 
 
Before the real experiment, computer simulation of simultaneous multi-slice excitation 
was performed.  First. Fig 5.13a shows the multi-frequency RF waveform for two-slice 
simultaneous excitation. Fig 5.13b shows its real and imaginary parts after Fourier Transform.  
Fig 5.14 shows the simulation of simultaneous excitation of two slices after applying a multi-
frequency RF pulse (++).  
 
               Fig 5.12 The multi-frequency RF waveform for two-slice simultaneous excitation.  
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Fig 5.13 shows the multi-frequency RF waveforms for excitation of two slices or (volumes), its real 
and imaginary part after Fourier Transform, and the magnitude after FT.  
 
 
 
Fig 5.14 shows the simulation of excitation of two slices simultaneously after applying a multi-frequency RF 
pulse.  
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5.7.2 Simultaneous Excitation of Two-slice by Modified Spin Echo  
Sequence and Hadamard Decoding 
 
Simultaneous excitation of multi-slices was implemented by using multi-frequency 
selective RF pulses together with the application of selection gradients during the RF pulse 
excitation.  The validation of this method to excite multiple slices has been tested using the 
modified simultaneous excitation of multi-slice spin echo sequence (see figure 5.12).  Both 
90° and 180° single-frequency excitation RF pulses were replaced by multi-frequency 
excitation RF pulses, which can excite two slices simultaneously. In order to display the slice 
profile image, the read out gradient in the X direction is shifted to the Z (slice selection) 
direction.  
In order to determine the accuracy of the selection, two small phantoms with different 
concentrations of contrast agent Gd-DTPA (Omniscan
TM
, gadodiamide injection 287mg/ml) 
were added to distilled water. Due to the T1 shortening effect of Gd-DTPA, different signal 
intensities would be obtained from the spin-echo images. Two phantoms were separated by a 
distance of 12mm. The slice thickness of the excited slices was 5mm. A cylindrical tube 
filled with distilled water was positioned beside the two phantoms for comparison of signal 
intensity. 
                   
Figure 5.15   Two Phantoms filled with Gd-DTPA were positioned with center to center separation 12mm. 
Phantom1 
Phantom2 
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Figure 5.16 Simultaneous multi-slice spin echo pulse sequence. This sequenced is modified based on a 
conventional spin echo pulse sequence with read out gradient moved from readout X direction to slice selection 
direction Z. Both 90° and 180° are multi-frequency excitation RF pulses. 
 
Fig 5. 17 (a) and (b) show the simultaneous multi-slice images obtained by using two-
volume multi-frequency excitation RF pulses. (a) uses RF ++ pulse, (b) uses RF+- pulse. It 
also demonstrates the capability of exciting two multiple slices simultaneously using this 
method. 
      
Fig 5.17a Two slices images simultaneously acquired     Fig 5.17b Two slices images simultaneously acquired              
                  by  using RF ++ pulse                     by using RF +-  pulse       
Phantom2 
Phantom1 
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 Fig 5.17 c and d show the reconstructed images of the the Hadamard decoded data sets. 
The two excited slices are well separated and displayed after Hadamard decoding.  
Fig 5.18 a and b show the normalized slice profiles of two simultaneously excited slices, 
while Fig 5.18 c and d show the normalized Hadamard decoded slice profiles individually, 
which are very cleanly decoded and keep the corresponding signal intensity because 
Hadamard encoding and decoding are linear procedures. (All slice profiles were drawn 
vertically through two slice images of different Gd-concentration phantoms.) 
 Fig 5.23 shows the linear relationship between Gd concentration and Spin-Echo signal 
intensity. 
      
  Fig 5.17c Decoded slice #1   Fig 5.17d Decoded slice #2 
 
Fig5.18a The slice profiles of two simultaneously                Fig5.18b The slice profiles of two simultaneously  
 Phantom1 
Phantom2 
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                excited slices by using RF ++ pulses  excited slices by using RF +- pulses 
 (All slice profiles were drawn vertically through two slice images of different Gd-concentration phantoms.) 
 
 
Fig5.18c Hadamard decoded sliced profile #1  Fig5.18d Hadamard decoded sliced profile #2 
From fig 5.18 c and d we can see that the signal intensity of each slice is also decoded 
correctly and cleanly.  
 
5.8 Computer Simulation of Four slices excitation and  
Hadamard Decoding 
 
5.8.1 Computer Simulation of Four slices excitation  
 For one-dimensional simultaneous four-slice excitation, according to section 5.6.2, four 
different RF pulses were designed and implemented. Fig 5.19a shows the multi-frequency RF 
waveform for four-slice simultaneous excitation. Fig 5.19b shows its real and imaginary parts 
after Fourier Transform.  Fig 5.19c shows the simulation of simultaneous excitation of four 
slices after applying a multi-frequency RF pulse (++++).  
Phantom1 
Phantom2 
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            Fig5.19a  Multi-frequency RF waveform of four-slice excitation (RF pulse + + + +) 
 
 Fig 5.19b shows the multi-frequency RF waveforms for excitation of four slices or  
(volumes), its real and imaginary parts after Fourier Transform, and the magnitude after FT. 
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Fig 5.19c shows the simulation of excitation of 4 slices simultaneously after applying a multi-frequency RF 
pulse.  
 
 
5.8.2 Simultaneous Excitation of Four-slice by Modified Spin Echo  
Sequence and Hadamard Decoding 
 
In order to prove the accuracy of the selection, four small phantoms with different 
concentration of contrast agent Gd-DTPA (Omniscan
TM
, gadodiamide injection 287mg/ml) 
were added to the distilled water. Due to the T1 shortening effect of Gd-DTPA, different 
signal intensities would be obtained from the spin-echo images. The four phantoms were 
positioned 12 mm apart with a total distance of 36 mm between phantoms 1 and 4 (fig5.20). 
The thickness of an excited slice was 5mm. A cylindrical tube filled with distilled water was 
positioned besides the four phantoms for comparison of signal intensity. 
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Figure 5.20   Four Phantoms filled with Gd-DTPA were positioned with center-to-center separation 12mm and 
36mm separately. 
 
 Fig 5. 21 a, b, c, and d show the simultaneous multi-slice images obtained by using four-
volume multi-frequency excitation RF pulses. (a) uses RF ++++ pulse, (b) uses RF+-+- pulse. 
c) uses RF ++-- pulse, (b) uses RF+--+pulse.  It also demonstrates the capability of exciting 
four slices simultaneously using this approach. 
 Fig 5.21 e, f, g, h show the reconstructed images of the Hadamard decoded data sets. The 
four excited slices are well separated and displayed after Hadamard decoding.   
 
             
          Fig 5.21a RF ++++ pulse      Fig 5.21b RF +-+- pulse 
 Fig5.21 a, b,c,d shows four-slice images simultaneously acquired  by using composite RF pulse  
                         (++++).(+-+-),(++--),(+--+) separately. 
 
Phantom1 
Phantom3 
Phantom4 
Phantom2 
Phantom4 
Phantom3 
Phantom2 
Phantom1 
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       Fig 5.21c RF ++--            Fig 5.21d RF +--+ 
     
      Fig 5.21e   Decoded Slice #1      Fig 5.21f  Decoded Slice #2 
            
Fig 5.21g  Decoded Slice #3       Fig 5.21h Decoded Slice #4 
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5.8.3 Slice Profile of Multi-Slice Excitation  
     
                
Fig5.22 a The slice profiles of two simultaneously                Fig5.22b The slice profiles of two simultaneously  
                excited slices by using RF ++++pulses  excited slices by using RF +-+-pulses 
 (All slice profiles were drawn vertically through four slice images of Gd-concentration phantoms.) 
 
Fig 5.22 a,b,c,d shows the slice profiles of four simultaneously excited slices by using 
composite RF pulse ( ++++ ),(+-+-).(++--),(+--+) separately. 
      
Fig5.22 c The slice profiles of two simultaneously                Fig5.22d The slice profiles of two simultaneously  
                excited slices by using RF ++-- pulses  excited slices by using RF +--+ pulses 
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                      Fig 5.22e Decoded profile#1   Fig 5.22f Decoded profile#2 
       
Fig 5.22g Decoded profile#3  Fig 5.22h Decoded profile#4 
 
 Figs 5.22 a, b, c, d show the slice profiles of four simultaneously excited slices, while 
Figs 5.22 e, f, g, h show the normalized Hadamard decoded slice profile individually which 
are very cleanly decoded and kept the corresponding signal intensity. 
Phantom1 
Phantom2 
Phantom3 
Phantom4 
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                               Fig 5.23 Linearity Test for Hadamard Encoding 
     Table 5.6  The residue signals in each Hadamard decoded slice (Figs 5.21 e,f,g,h.) (The residual signals 
were     normalized to each decoded slice signal intensity.) The average residual signal is 5.67%. 
 
 
 
 
 
 
 
 
 
    
  From table 5.6, the average residue signal for all the decoded slices is 5.67%.   
     In summary, from the above multi-slice excitation experiments, we proved that our 
designed Hadamard multi-frequency composite RF pulses could successfully and accurately 
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excite the slices we planned to localize and keep the corresponding signal intensity. And the 
contamination is within 10%.  
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Chapter 6 
 
Hadamard 2D* L-COSY Study of Prostate at 4T 
 
 
6.1 INTRODUUCTION 
 
Prostate adeno-carcinoma is distinctively characterized by the multi-focal and 
synchronous presence of different clusters of aggressiveness within the same tumor volume.  
Some of the malignant tumors will be easily overlooked by a single-voxel based MR 
spectroscopy method. Furthermore, due to the partial volume effects and the low 
concentration of metabolites in biological systems, the SNR is a critical factor for localized 
MRS studies. Although multi-dimensional (spatial dimension) 1D*(Spectral dimension) CSI 
[(2-5)] has shown its ability to distinguish prostate cancer from healthy prostate tissue with 
relatively high specificity, there are several limitations to this method. First, it has the same 
severe spectra overlap problem as 1D* (spectral dimension) MRS. Second, it suffers from 
voxel bleeding, which is an intrinsic problem of this technique. Third, the acquisition is 
usually cumbersome and relatively time-consuming. In order to obtain non-overlap spectra 
information and to provide accurate assessment of tumor extent and aggressiveness from 
different areas of the prostate, a multi-voxel with improved spectral resolution MR 
spectroscopic imaging technique within a reasonable acquisition time is needed.  
Two-dimensional 
1
H Magnetic Resonance Spectroscopy, which spread the metabolites 
resonance peaks on a two-dimensional surface, can help to differentiate most of the 
overlapping resonance peaks in conventional 1D* MRS spectrum. 2D* Localized Magnetic 
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Resonance Correlation SpectroscopY [{{1 Thomas, M.A. 2001;}}] (2D* L-COSY) is a 
technique that can give a better dispersion of J-cross-peaks for most of the interesting 
metabolites of prostate cancer (polyamines, citrate, choline, creatine etc) [(6)]. It offers a 
promising method for better detection and prognosis of prostate cancer. A COSY spectrum is 
acquired with varying echo times (TE), which encodes the indirect t1 dimension. The 
application of 2D* L-COSY in prostate examinations enables the spectral separation of 
metabolites creatine (Cr) and choline (Cho) from neighboring polyamine spermine (Spm), 
which has a similar resonance frequency [[(6)]. 
Hadamard encoded multi-voxel MRS [(7)] offers an effective way to overcome the 
limitations if simultaneous excitation of a small number of voxels is needed. This technique 
can decrease the voxel-bleeding of the excited voxels and leads to well-resolved spectra from 
the individual voxel. Higher signal-to-noise (SNR) ratio and relative short scan time can be 
gained compared to traditionally gradient encoded multi-voxel CSI MRS.  
The aim of this study is to develop a 2D* 
1
H Localized COSY sequence combined with a 
Hadamard encoding scheme capable of multi-voxel localization, which can be used in the 
study of prostate cancer to measure the specific prostate metabolites without spectral overlap 
and less voxel bleeding artifacts.  
In this chapter, the radiofrequency (RF) pulse in a single-voxel 2D* L-COSY sequence 
was modified to allow simultaneous excitation of two different volumes. It was implemented 
to resolve overlapped metabolite peaks with improved SNR, without sacrificing acquisition 
time and without spectral contamination. The quality of decoded Hadamard 2D* L-COSY  
spectrum was also tested. This technique is very useful for the comparison of diseased voxel 
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and normal voxel in prostate carcinoma. The spectra of the contra-lateral voxel can be used 
as a reference in the studies of prostate cancer.  
 
6.2 MATERIALS AND METHOD 
 
6.2.1 Sequence Diagram of Hadamard 2D* L-COSY 
 
All experiments were performed on a whole body 4T scanner integrated with an SMIS 
console (Surrey Medical Imaging System, UK). An in-house made birdcage coil was used for 
both RF transmission and signal detection.  
The scheme for the two-voxel 2D* Localized Hadamard chemical shift correlation 
experiment is based on the single-voxel Coherence trAnsfer Based spIN-Echo specTroscopy 
(CABINET) volume selection [(1)]. Three Gaussian chemical-shift-selective (CHESS, 60Hz) 
pre-pulses were applied followed by crusher gradients for water suppression (Sequence 
diagram is shown on Fig. 6.1). The RF pulse localization scheme consisted of three 
orthogonal slice-selective pulses (90°, 180°, 90°). Spoiler gradient pulses are placed 
symmetrically around the refocusing and transfer pulses to select the specific coherence 
pathway [1?]. The acquisition window is centered about the echo and moves with it as t1 is 
incremented generating a Spin-Echo Correlation SpectroscopY (SECSY)-mode acquisition 
[(8, 9)] (Details see chapter 4).  
 
6.2.2 Hadamard RF Pulse 
 
Hadamard encoding was implemented at the third slice-selective 90° RF pulse. The 
simultaneous excitation of two voxels can be designed as adjacently selected or selected with 
certain distance. Our RF pulse is a normal 9-lobe sinc pulse with pulse bandwidth of 4000Hz. 
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4000Hz pulse bandwidth was used to reduce the potential chemical shift displacement 
problem, which is caused by the different chemical shift values of water and fat (if in vivo 
study). The bandwidth of 4000Hz corresponds to a chemical shift of 0.6 mm/ppm at 4T.   
By applying the multi-frequency selective RF pulse with two-excitation bands in one 
slice selection direction, two localized volume will be excited simultaneously. The phases of 
the two composite Hadamard RF pulses are shown in table 6.1. In order to use the Hadamard 
encoding scheme, two consecutive scans will be performed. One acquisition uses a 
composite RF pulse, of which two phases positively superposed denoted as ‘++’. The second 
acquisition uses a different composite RF pulse, of which two phases reversely phased 
denoted as ‘+-’.  Therefore, the final phases in the two selected slices or (volumes), which 
result from the two consecutive acquisitions, synthesize differently.  
 
6.2.3 MRS Acquisition Parameters 
 
Since polyamine spermine has a short T2 relaxation decay time constant, short echo TE is 
preferred. The second dimension of the 2D* spectra was obtained by continuously acquiring 
echoes at different t1 delays. An 8-step phase cycling scheme was used on all three pulses. 
2D* L-COSY spectra were recorded using the following parameters: TR = 2000ms, minimal 
TE of 28ms, ∆=8ms, ∆′=6ms, and 32 t1 increments to sample the second frequency 
dimension (F1). A voxel of (15x15x15 mm
3
) was acquired. The number of excitation is 16. 
The raw data was acquired using 1024 complex points. The spectral window along the first 
dimension was 2.5 kHz, and 1.25kHz along the second dimension.  
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The parameters to test the quality of decoded Hadamard 2D* L-COSY spectrum were the 
same as two-voxel Hadamard 2D* L-COSY sequence except that the echoes collected was 
64 and the voxel size was 10 x 10 x 10mm
3
 instead of 15 x 15 x15mm
3
. 
 
Fig6.1 Two-voxel Hadamard 2D* L-COSY sequence diagram 
6.2.4 Phantom Preparation 
 
 Measurements were performed on two pairs of phantoms. One pair is a one 25-cm-
diameter cylinder tube containing a solution with 50 mM spermine (20% D2O, pH 7.0) and 
another cylinder tube containing 50 mM creatine (20% D2O). The second pair is one cylinder 
tube containing 50mM spermine (20% D2O, pH 7.0) and another cylinder tube containing 
50mM lactate.  Two voxels were selected according to figure 6.2 with slice-thickness and 
distance designed by a prepared Hadamard RF pulse. 
 
 
 
 
Figure 6.2   The position of two phantoms and two voxel selected by Hadamard RF pulse. 
Phantom1 
Phantom2 
Voxel 1 Voxel 2 
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    In order to test the quality of Hadamard decoded 2D* L-COSY MRS spectrum, one 
phantom with 60mM spermine, 30mM choline, and 36mM creatine (pH=7.0, 20%D2O) was 
prepared. Fig6.3 showed the Hadamard two-voxel selection. The center-to -center distance of 
these two voxels was 15mm. 
 
 
 
 
 
 
 
 
         Fig 6.3 The phantom prepared for testing the quality of decoded Hadamard 2D* L-COSY spectrum. 
 
6.2.5 Post-Processing  
 
The self customized MATLAB (Mathworks, Inc., USA) programs and free matNMR 
software package (Jacco van Beek [(10)]) were utilized to analyze the spectra. After baseline 
correction and phase correction, the raw data were apodized with sine-bell windows 
functions along t2 and zero-filled to 128 x 2048 prior to two-dimensional Fast Fourier 
Transformation. All 2D* spectra were presented as contour plots. The resulting spectrum was 
displayed in magnitude mode. 
In order to test the quality of decoded Hadamard 2D* L-COSY MRS spectrum, the cross-
peaks volumes of polyamine spermine, choline and the height of creatine (didn’t show cross 
peak in our results) were also integrated for comparison.  
 
Hadamard 
Voxel 1 
Hadamard 
Voxel 2 
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6.2.6 Post-Processing Flow-Chart 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Fig 6.4 Flow chart of Post-processing for Hadamard Encoded 2D* L-COSY spectra 
  
INPUT 
Total number of files:  K (# of data files acquired) 
Spectral width in F1 and F2 axis, Matrix size N x M. 
Number of increments in t1 direction. 
   Start 
For i=1,K  
Read in raw 
data file 
Extract pure FID 
Data matrix 
After Hadamard Decoding  
 Obtained K decoded data sets 
i <K? 
Yes 
No 
Base line correction 
Phase correction 
    Apodization by sine-bell function  
           Zero-filling 
             2D FFT  
    Contour plot display Axes rescaled to ppm or Hz  
  (Using water peak signal  (4.7ppm) as reference) 
 
Finish 
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6.3 RESULTS  
 
Table 6.1 Assignments of Off-Diagonal Peaks in the Upper Triangle 
Metabolites 
F1 coordinate 
(ppm) 
F2 coordinate 
(ppm) 
Polyamine 
Spermine 
3.1~3.15 2.1 
3.1~3.15 1.8 
Lactate 4.1 1.31 
 
1) Spermine- Lactate two-compartment pair 
       
  Fig.6.5A.Hadamard RF ++ pulse, 2D contour                            Hadamard RF ++ pulse, 3D contour 
          
                Fig 6.5B   Hadamard RF +- pulse, 2D contour                      Hadamard RF +- pulse, 3D contour 
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Fig6.5 C1. Hadamard decoded Lactate (4.1ppm/1.31ppm) , contour plot in 3D 
           
             Fig6.5 C2. Hadamard decoded Spermine (3.1ppm/1.8ppm, 3.1ppm/2.1ppm), contour plot in 3D 
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Fig6.5 D1, Hadamard decoded Lactate (4.1ppm/1.31ppm), contour plot in 2D 
 
         Fig 6.5D2, Hadamard decoded Spermine (3.1ppm/1.8ppm, 3.1ppm/2.1ppm), contour plot in 2D 
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2). Spermine-Creatine pair 
    
Fig6.6 C1. Hadamard decoded Creatine (3.04ppm, 3.94ppm, no cross peaks), contour plot in 3D 
 
Fig 6.6 C2, Hadamard decoded Spermine (3.1ppm/1.8ppm, 3.1ppm/2.1ppm), contour plot in 3D 
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Fig6.6 D1. Creatine (3.04ppm, 3.94ppm, no cross-peaks), contour plot in 2D 
 
Fig 6.6 D2, Spermine (3.1ppm/1.8ppm, 3.1ppm/2.1ppm), contour plot in 2D 
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  The chemical shifts of the observed cross-peaks are displayed in table 6.2. The decoded 
spectra are shown in Figure 6.5 and Figure 6.6. In the 2D* L-COSY MR spectra, the 
diagonal peaks along F1 = F2 resembles the conventional 1D* spectral resonances. The 
Hadamard decoded spermine from two pairs of phantoms (Fig6.5C2, Fig6.5D2, Fig6.6C2, 
Fig6.6D2)) shows two well-separated cross-peaks at (3.1 ppm / 1.8 ppm), (1.8 ppm / 3.1 ppm) 
and (3.1 ppm / 2.1 ppm), and (2.1 ppm / 3.1 ppm).  
The Hadamard decoded COSY cross-peaks (Fig6.5C1, Fig6.5D1) due to methyl and 
methylene protons of Lactate were well isolated at (1.31ppm/4.1ppm, 4.1ppm/1.3ppm).  
The Hadamard decoded COSY cross- peaks of Creatine (Fig6.6C1, Fig6.6D1) were not 
resolvable, peaks shown only on the diagonal axis F1 = F2 at 3.04ppm and 3.94ppm. 
Fig 6.5 A and B show 2D correlation Hadamard encoded spectra obtained from a pair of 
two-compartment phantoms that contain 50mM polyamine and 50mM creatine separately. (A 
corresponds to spectra using positive phased Hadamard RF pulses, B corresponds to spectra 
using opposite phased Hadamard RF pulses). Fig 6.5 C1 (Lactate, contour plot in 3D), Fig 
6.5C2(Spermine, contour plot in 3D) and Fig 6.5 D1(Lactate, contour plot in 2D), Fig 6.5 
D2(Spermine, contour plot in 2D) showed extracted spectra after Hadamard decoding 
corresponding to the two encoded voxels. Data post-processing including Hadamard-
decoding was performed by self-customized MATLAB (Mathworks, Inc. USA) programs 
and matNMR [(10)].  
Figure 6.6 A and B show 2D correlation Hadamard encoded spectra obtained from a pair 
of two-compartment phantoms that contain 50mM Polyamine and 50mM lactate separately. 
(A corresponds to spectra using positive phased Hadamard RF pulse, B corresponds to 
spectra using opposite phased Hadamard RF pulse). Figure 6.6C1 (creatine, contour plot in 
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3D), Figure 6.6C2 (Spermine, contour plot in 3D) and Figure 6.6D1 (creatine, contour plot in 
2D), Figure 6.6D2 (Spermine, contour plot in 2D) showed extracted spectra after Hadamard 
decoding corresponding to the two encoded voxels. Data post-processing including 
Hadamard-decoding was performed by self-customized MATLAB (Mathworks, Inc. USA) 
programs and matNMR.  
 
      Fig 6.7a    Decoded Hadamard 2D* L-COSY spectrum from voxel 1 
 
     Fig 6.7b    Decoded Hadamard 2D* L-COSY spectrum from voxel 2 
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Figs 6.7a and b showed the decoded Hadamard 2D* L-COSY spectra from voxel 1 and 
voxel 2 respectively. Table 6.3 shows the quantified volume of cross-peaks ratios of 
spermine, choline and creatine peak height. 
Table 6.2 The integrated volume of cross-peaks ratios of spermine, choline and creatine peak height. 
 voxel 1 voxel 2 
Spermine 1  1± 1.53% 
Choline 1  1± 5.91% 
Creatine peak height 1  1± 5.13% 
 
In summary, accurate localization was obtained by Hadamard encoded RF pulses and the 
extracted spectra showed only minor contamination. The level of contamination was within 
6.00 %, which was caused by the instability of the RF transmitter, receiver of the customized 
coil, inhomogeneity of magnetic field and calibration of RF pulses. It also results from the 
non-perfect slice profile of the excitation pulse.  
 
6.4 DISCUSSION 
 
The Advantages of using 2D L-COSY for Prostate Cancer Study 
2D* spectroscopy enables the detection of more metabolites compared to the 
conventional 1D* spectroscopy technique. The ability to simultaneously observe many 
metabolites in a single dataset is a powerful feature of many 2D* techniques and increases 
the range of molecules that may be exclusively assigned. 2D* L-COSY can overcome the 
spectral overlap problem even in low magnetic fields.  It allows separation of most 
overlapping peaks for coupled spin systems that give rise to off-diagonal peaks [(1, 11)]. 
Furthermore, 2D L-COSY offers several useful attributes especially for those nuclei with 
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relatively short transverse relaxation T2 time constants such as polyamine spermine and 
lactate, which are very well resolved in the 2D* correlation spectrum.  
 
Characteristics of RF Hadamard Encoding 
RF Hadamard encoding can be implemented by combining with Hadamard matrix. 
Hadamard simultaneous multi-slice excitation involves encoding the radio-frequency 
channels according to the signs in an N x N Hadamard matrix. The Point Spread Function 
(PSF) of Hadamard encoding is a rectangular pulse since the Hadamard basis function is a 
train of step function.  
 
Hadamard Multi-Voxel 2D L-COSY vs. Multi-Voxel CSI—General Comparison 
Unlike the Fourier based CSI technique, Hadamard enables one to select a smaller number 
of voxels (2, 4, 8 etc.). It is better for small FOVs with shimming considerations, and limited 
partitions (usually <=8) due to limited power deposition [(12)]. Additionally, these voxels 
can be selected either contiguously or non-contiguously by appropriate encoding. Therefore, 
the location of the voxels can be selectively placed. It allows the option of voxel-shifting 
within the dataset so as to optimally align spectral voxels to an imaging abnormality. It has a 
superior point spread function (PSF). 
Fourier encoding CSI usually utilizes gradients to achieve spatial encoding. Easily 
implemented CSI can acquire more voxels over large fields of view (FOVs) than Hadamard 
MRS, and has a good local point-spread function (PSF) [(13)]. The individual voxel 
spectrum of any spatial location can be obtained by simple N-dimensional Fourier Transform. 
CSI also allows voxel shift flexibility to align with abnormality, but all the voxels have to be 
contiguous. Another disadvantage of CSI is its long data acquisition time. Fourier encoding 
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is usually integrated with Hadamard encoding to complement each other’s strengths and 
weakness [(14),(15),(16)]. One common feature of Hadamard MRS and Fourier based CSI is 
that both techniques suffer from chemical shift mis-registration artifacts [(17)]. 
  
 
Voxel Bleeding 
The acquisition of ‘non-contaminated’ data is valuable for the quantitative assessment of 
metabolite levels, which is very important for tumor diagnosis. In addition to N  
improvement of SNR, another advantage of Hadamard Spectroscopy over one spectral 
dimension (1D*) multi-voxel Chemical Shift Imaging (CSI) is fewer voxel bleeding artifacts. 
Accurate MRS detection depends on correct assignment of the signal in the localized 
volumes of interest. Since metabolic level changes between diseased and healthy tissues are 
often very small, even minor voxel bleed-in and bleed-out may adversely deviate focal 
quantification and regional assessment, which may hinder clinical practice. Unfortunately, 
both Hadamard and CSI localization schemes suffer from inter-voxel signal leakages, also 
known as ‘voxel bleed’ [(18),(14, 15)]. The bleed, which is due to continuous phase 
dispersion across the voxels in Fourier encoding, is intrinsic [(18),(19, 20)]. While voxel 
bleed (cross-talk) in Hadamard encoding is due to instrument limitations, e.g., finite RF 
bandwidth and gradient strengths lead to nonrectangular, approximately Gaussian or 
trapezoidal slice profiles. 
Traditional Chemical Shift Imaging (CSI) MRS technique usually utilizes phase encoding 
gradients for spatial encoding. However, CSI MRS suffers from signal loss. According to 
Maudsley [18], there was an amount up to 13% signal intensity loss due to intrinsic spin 
dephasing within a voxel, which was caused by the applied phase encoding gradient.  Since 
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multi-voxel CSI MRS technique is relatively time-consuming, 8~16 phase encoding steps 
(usually less than 32) are normally used leading restricted k-space sampling. The truncated k-
space sampling will create Gibbs ringing artifacts. Therefore, due to point spread function 
(PSF) effects, DFT reconstruction leads to inter-voxel signal leakage. Multi-voxel CSI is 
usually contiguous selection. 
       While Hadamard RF encoding technique does not use phase encoding gradients, 
therefore, no de-phasing problem caused by phase encoding gradient. As we mentioned 
before, the PSF of Hadamard encoding is a rectangular pulse.  Therefore, the voxel bleeding 
in Hadamard encoding MRS is usually caused by imperfect RF profile or limit of gradient 
strength. And compared to traditional multi-voxel CSI MRS, Hadamard MRS has the 
flexibility of non-contiguous selection of voxels. 
 Different methods [(20),(21),(22)] have been developed to improve the PSF function of 
Fourier based CSI to decrease the voxel leakage at the price of increased nominal voxel size 
or complex post-processing.  
On the other hand, due to the unique Hadamard encoding, new strategies have been 
developed.  The ability to reduce bleed with Hadamard encoding has been demonstrated in 
three-dimensional (3D) MRS of the human brain [(14, 15)]. Another simple and 
straightforward modification of the Hadamard RF pulse synthesis [(13)], which takes 
advantage of its unique ability to encode non-contiguous voxels, can be exploited to reduce 
the inter-voxel bleeding significantly to noise level. This strategy is based on the property 
that Hadamard MRS in contrast to chemical-shift imaging (CSI), which is different from the 
bleed-reducing modification in CSI, the proposed solution by Goelman does not come at the 
price of increasing the nominal voxel dimensions.  
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Other Multi-volume 2D L-COSY Techniques 
2D L-COSY is collected echoes at different t1 delays. However, all signal localization 
schemes utilizing echo formation suffer from modulation of the signal from J-coupled spins 
as a function of the echo time, which usually cause line shape distortion and baseline roll. It 
also suffers from an additional intrinsic loss of half of the available signal (e.g. CABINET 
50% sensitivity). Welch et. al  [(25)] described a COSY sequence, that utilizes Image 
Selected In Vivo Spectroscopy (ISIS) volume localization to provide ‘echo-free’ spin-
preparation (i.e. FID signal only), which avoids the corresponding relaxation losses and J-
modulation effects.  Welch claimed that this ISIS-COSY sequence allowed acquisition of 
spectra with well resolved cross-peaks within a total acquisition time that is acceptable for in 
vivo animal experiments and which could be quantified by calculation of the volume under 
the cross-peaks. The disadvantages of this ISIS-COSY method compared to the Hadamard 
COSY is that it does not measure a signal exclusively from the volume of interest (VOI), 
thus it is more difficult to do localized shimming on the voxel itself. Small voxel FID data 
require at least 8 measurements, which is more sensitive to motion artifacts. 
 
Optimization of Parameters In This Study 
Parameters including minimum echo time, i.e., the initial t1 value, t1-increment delay, and 
the number of echoes collected, have to be optimized according to the requirement of digital 
resolution for different spin systems [(9, 23)].  The sampling period in the second spectral 
dimension has to be adapted to the different spin systems of the metabolites according to 
their T2 decay constants and J coupling constants.  
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In this simultaneously multi-voxel excitation study, part of the contaminations comes 
from the non-perfect slice profile of the excitation pulse. In this study, only a normal 9-lobe 
sinc RF pulse is used. A Shinnar-Le Roux Method [(24)] of RF pulse design for better 
excitation profile is recommended to obtain a better RF pulse profile. 
Shorter acquisition time together with spectral dispersion enhancement are the major 
concerns of this study. Total acquisition time for the spectra in Figs. 6.4 C–3F was 34 min. 
However, an acquisition of 17 min was possible for the detection of short T2 decay 
metabolites such as polyamine and lactate if TR decreased half (Sensitivity decreases half). 
 
Voxel Numbers 
Regarding voxel numbers, it takes longer to collect 4-voxel and 8-voxel Hadamard 2D 
MRS for acquisition and decoding the 2D MR spectra. Consequently, 2D MR spectra will be 
more easily affected by motion artifacts. Compared to 4-voxel and 8-voxel 2D methods, two-
voxel Hadamard 2D L-COSY is more easily implemented with the flexibility to position the 
voxels and also suffers less from motion artifacts for in vivo studies. 
 
SNR Improvement 
A smaller voxel is preferred in clinical practice to decrease the partial volume effects. As 
a result, improving the SNR for the observed metabolites is a critical factor for MRS study. 
In Hadamard encoded experiments, multi-radiofrequency selective RF pulses are used for 
spatial encoding, while in Fourier based 
1
H CSI, the phase-encoding gradients are used 
instead. The multi-voxel Hadamard spectroscopic technique has the benefits of improving the 
SNR when compared to single-voxel spectroscopic techniques. In general, a  fold gain in 
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sensitivity is obtained for N encoded voxels. Additionally, by appropriate encoding, these 
voxels can be selected either contiguously or non-contiguously. Therefore, the location of 
voxels can be selectively placed.  
Furthermore, in our study, a SECSY acquisition mode is also used to further improve the 
SNR, although a phase correction is needed to correct the extra delay of echo acquisition. 
Apodization at acquisition and post-processing will also help to improve SNR. A t2 matching 
filter [(9)] at the acquisition stage is another popular way in 2D MRS to further improve SNR. 
 
The advantages of Multi-voxel 2D L-COSY And Potential Use In The Future 
The heterogeneity and mutli-focal characteristics of prostate cancer make two-voxel 
Hadamard 2D L-COSY a very useful tool to detect the healthy and diseased tissue 
simultaneously. With the help of the Hadamard multi-voxel 2D Localized MR spectroscopy 
technique, well-resolved 2D* decoded spectrum can be provided. With the increased SNR, 
the differences in metabolites ratios between tumor and the surrounding normal tissues may 
be distinguished. Furthermore, the extent of cancer can be better determined. This less-voxel 
bleeding technique can be applied in particular to study metabolic changes for multi-focal 
prostate adeno-carcinoma.  
 
6.5 CONCLUSION 
 
The observation of a large number of resonances requires high field strength and very 
short echo time. But with the successful implementation of the Hadamard 2D L-COSY multi-
voxel sequence, this can be accomplished with magnetic field lower than (or equal to) 4T. 
Compared to single-voxel acquisition, the combination of 2D Localized COSY and 
Hadamard encoding in our study allows the simultaneous acquisition of multiple voxels 
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without an increase in the experimental duration, but with the benefit of increased spectral 
dispersion and SNR.  
Our results demonstrated that multi-voxel 2D 
1
H MR correlation spectroscopy can be 
applied in prostate phantom with a favorable temporal resolution and reasonable acquisition 
time. Two-volume localization was obtained using Hadamard encoding with limited signal 
contamination. This method is preferable to Fourier phase-encoding methods (
1
H CSI) when 
matrices of limited size are sampled (2, 4, or 8 etc). The gain in spectral resolution and 
improvement of signal to noise in comparison to one-dimensional spectroscopy make it 
possible to gain access to more prostatic metabolites. Detection of resonances without 
contamination of other resonances is possible for most correlation peaks recorded.   
In the future, Hadamard multi-voxel 2D* L-COSY can be used to detect any tumor 
characterized with multi-focal and heterogeneity to improve spectral dispersion and signal to 
noise ratio. This method can be potentially used to measure biochemical changes of multiple 
tumor target volumes, detect metabolic markers of different tumor phenotypes etc.  
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Chapter 7 
 
Dissertation Summary 
 
7.1  Benefits  
 
       2D localized 
1
H MR spectroscopy has the ability to overcome the spectral overlap even 
at lower magnetic fields, which is a usual problem of 1D 
1
H MR spectroscopy.  2D localized 
J-resolved PRESS MRS, i.e. 2D L-JPRESS and 2D localized chemical shift correlated 
spectroscopy (namely, 2D L-COSY) were implemented on a 4T MRI scanner. 2D cross-
peaks due to J-coupled metabolites from 2D L-COSY spectra have better spectral dispersion 
compared to the 2D J-resolved cross peaks.  
The multi-voxel (N-voxel) Hadamard spectroscopic technique has the benefits of either 
reducing the voxel size or reducing the data acquisition time or a combination of both owing 
to the improvement of the SNR when compared to single-voxel spectroscopic techniques in a 
similar way as chemical shift imaging (CSI). In general, an N  fold gain in sensitivity is 
obtained for N encoded voxels. The use of smaller voxels requires improvement of the signal 
to- noise ratio for some of the observed metabolites. Partial volume artifacts will be fewer 
due to the smaller voxel size.  This will allow the use of smaller voxels with no information 
loss. Compared to 
1
H MRSI, the number of Hadamard encoded voxels is limited because of 
the pulse power requirements. However, Hadamard encoding is less prone to voxel bleeding 
(cross-talk) in comparison to conventional CSI methods. 
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If a Hadamard Encoding multi-voxel MRS pulse sequence is implemented in the 
interleaved mode, the steps in spectra acquisition such as shimming, water suppression and 
CHESS RF adjustments are eliminated, which are extremely time consuming and may limit 
the utility of MR spectroscopy. The multi-voxel data can be acquired within a combined scan 
without any increases in scan time compared with the single voxel PRESS. 
Unlike the Fourier based CSI technique, Hadamard enables one to select a smaller 
number of voxels (2, 4, 8 etc.). Additionally, by appropriate encoding, these voxels can be 
selected either contiguously or non-contiguously, therefore the location of voxels can be 
selectively placed.  This makes this MRS technique feasible for clinical applications. 
Different tissue types (especially heterogeneous tissue in one organ), contra-lateral region of 
interest, different regions of interest can be studied, which allows the selection of presumably 
unaffected healthy areas to serve as internal control regions, therefore can minimize the 
effects of inter-subject variability on data interpretation.  
One of the strengths of this technique is the ability to provide spatially localized 
quantification of metabolism of prostate phantom via MRS and anatomy by MR imaging, 
noninvasively. The ability to perform noninvasive MRS and MRI sequences provides a 
powerful tool to study and monitor the dynamic progression of prostate cancer in the future. 
 
7.2 Conclusion 
 
Compared to single-voxel acquisition, the combination of localized 2D Localized 
1
H 
COSY and Hadamard encoding allows the simultaneous acquisition of multiple voxels 
without an increase in the experimental duration, but with the benefit of increased spectral 
dispersion and SNR.  Our results demonstrated that multi-voxel 2D 
1
H MR correlation 
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spectroscopy can be applied in prostate phantoms with a favorable temporal resolution. Two-
volume localization was obtained using Hadamard encoding, with limited signal 
contamination as shown on a two-compartment phantom. This method is preferable to phase-
encoding methods (
1
H MRSI) when matrices of limited size are sampled (<=8). The gain in 
spectral resolution and improvement of signal to noise, in comparison to one-spectral 
dimension spectroscopy, give access to a larger number of prostatic metabolites. Detection of 
resonances without contamination of other resonances is possible for most correlation peaks 
recorded. With the successful implementation of this sequence, this technique can be tested 
in clinical trials of prostate carcinoma for further study. 
 
7.3       Original Contributions 
 
The original contribution of this work is the development and implementation of a new 
Hadamard multi-voxel 2D localized COSY MRS technique on a whole-body 4T MR system. 
This technique can not only provide multi-regional MRS analysis with the improved SNR 
ratio, but also dramatically improve the spectral resolution, which can solve the severe 
resonances overlap problem in 1D 
1
H MR spectra. The SNR ratio is a critical factor for in 
vivo study due to the low concentration of metabolites. By using this technique, more 
metabolites can be identified and more information about the metabolites can be gained from 
the extended 2D MRS spectra. The 2D L-COSY technique has the ability to clearly resolve 
the cross-peaks of the investigated metabolite, which provides extra information about the 
metabolite. This offers an opportunity to accurately follow the metabolism in vivo.  
This multi-voxel 2D MRS technique can be utilized to monitor any specific metabolic 
biomarker of any disease, which is overlapped in the 1D proton MR spectrum but can be well 
 155 
resolved with 2D L-COSY. In the future, this new technique can be applied to longitudinally 
monitor the metabolic changes of prostate cancer biomarker-polyamines in an animal model 
being treated with chemo-preventive agents such as DFMO. Treated and untreated (control) 
groups of animals will be compared. The outcome of this study may provide a better 
understanding of the in vivo action of DFMO longitudinally towards prevention of prostate 
cancer.  
Another contribution of this work is the comparison of currently prevalent 2D J-resolved 
MRS with the 2D L-COSY technique. The advantages and disadvantages of both techniques 
are thoroughly investigated. As a result, a new diagnostic strategy is recommended based on 
this comparison.  
This new technique was developed independently and is not currently commercially 
available. 
 
7.4        Further Research  
 
So far, the relatively long acquisition time of 2D MRS prevents it from being popularly 
used in clinical practice. Rapid encoding of k-space (spiral or echo-planar) could be 
combined with the 2D L-COSY technique, which can markedly accelerate the data 
acquisition, therefore decrease the minimum experiment time (at the price of a decrease in 
SNR) to make it more practical for clinical applications. 
